MedAssets (MDAS) Inactive 10-K2 Mar 152014 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Dec. 31, 2014	Feb. 12, 2015	Jun. 30, 2014
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Trading Symbol	MDAS
Entity Registrant Name	MEDASSETS INC
Entity Central Index Key	1254419
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		60,221,738
Entity Public Float			$1,333,974,905

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$12,100	$2,790
Accounts receivable, net of allowances of $2,641 and $2,568 as of December 31, 2014 and December 31, 2013, respectively	127,741	87,636
Deferred tax asset, current portion	5,782	4,535
Prepaid expenses and other current assets	30,557	24,059
Total current assets	176,180	119,020
Property and equipment, net	170,318	157,747
Other long term assets
Goodwill	1,058,414	1,027,847
Intangible assets, net	276,407	267,440
Other	37,477	41,695
Other long term assets	1,372,298	1,336,982
Total assets	1,718,796	1,613,749
Current liabilities
Accounts payable	26,910	24,066
Accrued revenue share obligation and rebates	91,864	77,398
Accrued payroll and benefits	32,784	41,587
Other accrued expenses	9,040	12,126
Deferred revenue, current portion	76,034	46,523
Current portion of notes payable	29,583	15,500
Current portion of finance obligation	294	255
Total current liabilities	266,509	217,455
Notes payable, less current portion	526,417	424,000
Bonds payable	325,000	325,000
Finance obligation, less current portion	8,475	8,781
Deferred revenue, less current portion	15,418	16,369
Deferred tax liability	116,607	121,083
Other long term liabilities	13,883	11,272
Total liabilities	1,272,309	1,123,960
Commitments and contingencies
Stockholders' equity
Common stock, $0.01 par value, 150,000,000 shares authorized; 60,199,000 and 61,740,000 shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively	602	617
Additional paid-in capital	694,235	717,132
Accumulated deficit	-248,350	-227,960
Total stockholders' equity	446,487	489,789
Total liabilities and stockholders' equity	$1,718,796	$1,613,749

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]
Allowances on accounts receivable	$2,641	$2,568
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	60,199,000	61,740,000
Common stock, shares outstanding	60,199,000	61,740,000

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenue:
Administrative fees, net	$291,363	$289,475	$266,915
Other service fees	428,866	390,941	373,206
Total net revenue	720,229	680,416	640,121
Operating expenses:
Cost of revenue (inclusive of amortization expense of $3,131, $2,157 and $2,416 for the fiscal years ended December 31, 2014, 2013 and 2012, respectively)	171,852	151,950	138,618
Product development expenses	31,133	30,874	28,483
Selling and marketing expenses	67,426	61,427	60,438
General and administrative expenses	237,617	231,826	218,194
Restructuring, acquisition and integration-related expenses	7,512	10,070	6,348
Depreciation	48,096	40,803	30,190
Amortization of intangibles	57,593	62,723	72,652
Impairment of goodwill	52,539
Total operating expenses	673,768	589,673	554,923
Operating income	46,461	90,743	85,198
Other income (expense):
Interest (expense)	-45,563	-46,907	-66,045
Loss on debt extinguishment			-28,196
Other income	315	287	685
Income (loss) before income taxes	1,213	44,123	-8,358
Income tax expense (benefit)	21,603	16,682	-1,480
Net (loss) income	($20,390)	$27,441	($6,878)
Basic and diluted income (loss) per share:
Basic net (loss) income per share	($0.34)	$0.46	($0.12)
Diluted net (loss) income per share	($0.34)	$0.45	($0.12)
Weighted average shares - basic	59,811	59,705	57,452
Weighted average shares - diluted	59,811	61,178	57,452

Consolidated_Statements_of_Ope1

Consolidated Statements of Operations (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Amortization expense	$3,131	$2,157	$2,416

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive (Loss) Income (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
Net (loss) income	($6,878)
Unrealized (loss) from hedging activities for the period	-1,687
Income tax benefit related to hedging activities for the period	521
Reclassification of realized loss into earnings from hedging activities	8,209
Reclassification of income tax benefit into earnings from hedging activities	-2,982
Comprehensive (loss) income	($2,817)

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Equity (USD $)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
In Thousands, except Share data	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Balances at Dec. 31, 2011	$418,613	$579	$670,618	($248,523)	($4,061)
Balances, Shares at Dec. 31, 2011		57,857,000
Issuance of common stock from stock option and SSAR exercises and restricted stock issuances, net	7,684	15	7,669
Issuance of common stock from stock option and SSAR exercises and restricted stock issuances, net		1,529,000
Stock compensation expense	10,291		10,291
Repurchase of common stock	-600	-1	-599
Repurchase of common stock, Shares	-62,334	-62,000
Excess tax benefit from equity award exercises, net	452		452
Unrealized loss from hedging activities	-1,166				-1,166
Reclassification of realized loss into earnings from hedging activities	5,227				5,227
Net income	-6,878			-6,878
Balances at Dec. 31, 2012	433,623	593	688,431	-255,401
Balances, Shares at Dec. 31, 2012		59,324,000
Issuance of common stock from stock option and SSAR exercises and restricted stock issuances, net	10,116	24	10,092
Issuance of common stock from stock option and SSAR exercises and restricted stock issuances, net		2,416,000
Stock compensation expense	14,496		14,496
Excess tax benefit from equity award exercises, net	4,113		4,113
Net income	27,441			27,441
Balances at Dec. 31, 2013	489,789	617	717,132	-227,960
Balances, Shares at Dec. 31, 2013	61,740,000	61,740,000
Issuance of common stock from stock option and SSAR exercises and restricted stock issuances, net	3,610	4	3,606
Issuance of common stock from stock option and SSAR exercises and restricted stock issuances, net		379,000
Shares surrendered to pay taxes on vesting of restricted stock	-3,197	-1	-3,196
Shares surrendered to pay taxes on vesting of restricted stock, shares		-135,000
Stock compensation expense	17,849		17,849
Repurchase of common stock	-42,771	-18	-42,753
Repurchase of common stock, Shares	-1,784,645	-1,785,000
Excess tax benefit from equity award exercises, net	1,597		1,597
Net income	-20,390			-20,390
Balances at Dec. 31, 2014	$446,487	$602	$694,235	($248,350)
Balances, Shares at Dec. 31, 2014	60,199,000	60,199,000

Consolidated_Statements_of_Sto1

Consolidated Statements of Stockholders' Equity (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012
Income tax benefit (expense) related to hedging activities for the period	$521
Tax benefit on realized loss from hedging activities	-2,982
Accumulated Other Comprehensive Loss [Member]
Income tax benefit (expense) related to hedging activities for the period	521
Tax benefit on realized loss from hedging activities	$2,982

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Operating activities
Net (loss) income	($20,390)	$27,441	($6,878)
Adjustments to reconcile (loss) income from continuing operations to net cash provided by operating activities:
Bad debt expense	195		735
Depreciation	51,227	42,960	32,049
Amortization of intangibles	57,593	62,723	73,209
Impairment of goodwill and intangible assets	52,539	3,551	0
Loss on sale of assets	260	90	370
Noncash stock compensation expense	17,849	14,496	10,291
Excess tax benefit from exercise of equity awards	-1,958	-6,032	-1,495
Amortization of debt issuance costs	3,805	3,807	7,390
Loss on debt extinguishment			19,987
Noncash interest expense, net	409	456	514
Deferred income tax (benefit) expense	-5,564	2,013	-3,212
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	-30,547	9,010	6,958
Prepaid expenses and other assets	-4,598	-2,268	-3,303
Other long-term assets	1,325	-414	1,969
Accounts payable	3,618	-374	5,572
Accrued revenue share obligations and rebates	14,466	3,124	3,368
Accrued payroll and benefits	-10,403	1,502	6,820
Other accrued expenses and long-term liabilities	-1,470	-1,926	-4,013
Deferred revenue	10,659	-7,257	7,542
Cash provided by operating activities	139,015	152,902	157,873
Investing activities
Purchases of property, equipment and software, net	-21,034	-17,643	-26,221
Capitalized software development costs	-42,224	-41,175	-40,205
Acquisitions, net of cash acquired	-141,256
Cash used in investing activities	-204,514	-58,818	-66,426
Financing activities
Proceeds from notes payable			550,000
Borrowings from revolving credit facility	216,080		140,000
Repayment of notes payable	-25,500	-120,500	-578,650
Repayment of revolving credit facility	-74,080		-130,000
Repayment of finance obligations	-676	-676	-676
Payment of deferred purchase consideration			-120,136
Debt issuance costs	-615		-9,777
Excess tax benefit from exercise of equity awards	1,958	6,032	1,495
Issuance of common stock, net	3,610	10,116	7,684
Purchase of treasury shares, including shares surrendered for tax withholdings	-45,968		-600
Cash provided by (used in) financing activities	74,809	-105,028	-140,660
Net increase (decrease) in cash and cash equivalents	9,310	-10,944	-49,213
Cash and cash equivalents, beginning of period	2,790	13,734	62,947
Cash and cash equivalents, end of period	$12,100	$2,790	$13,734

Description_of_Business_and_Si

Description of Business and Significant Accounting Policies

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Description of Business and Significant Accounting Policies

1. DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES

We provide technology-enabled products and services that, together, deliver solutions designed to reduce total cost of care, enhance operational efficiency, align clinical delivery with advance care coordination and improve revenue performance for hospitals, health systems and other ancillary healthcare providers. Our client-specific solutions are designed to efficiently analyze detailed information across the spectrum of cost, operations, clinical delivery and reimbursement. Our solutions integrate with existing operations and enterprise software systems of our clients and provide financial improvement with minimal upfront costs or capital expenditures. Our operations and clients are primarily located throughout the United States and to a limited extent, Canada.

Basis of Presentation

The consolidated financial statements include the accounts of MedAssets, Inc. and our wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have prepared the accompanying consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”).

Use of Estimates

The preparation of the financial statements and related disclosures in conformity with GAAP and pursuant to the rules and regulations of the SEC, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from those estimates. We believe that the estimates, assumptions and judgments involved in revenue recognition, allowances for doubtful accounts and returns, product development costs, share-based payments, business combinations, impairment of goodwill, intangible assets and long-lived assets, and accounting for income taxes have the greatest potential impact on our consolidated financial statements.

Cash and Cash Equivalents

All of our highly liquid investments with original maturities of three months or less at the date of purchase are carried at cost which approximates fair value and are considered to be cash equivalents. Currently, our excess cash is voluntarily used to repay our swing-line credit facility, if any, on a daily basis and applied against our revolving credit facility on a routine basis when our swing-line credit facility is undrawn. In addition, we may periodically make voluntary repayments on our term loans. Cash and cash equivalents were $12,100 and $2,790 as of December 31, 2014 and December 31, 2013, respectively, and our swing-line balance was zero during those reporting periods. We had $152,000 and $10,000 outstanding on our revolving credit facility as of December 31, 2014 and 2013, respectively. In the event our cash balance is zero at the end of a period, any outstanding checks are recorded as accrued expenses. See Note 6 for immediately available cash under our revolving credit facility.

Additionally, we have a concentration of credit risk arising from cash deposits held in excess of federally insured amounts totaling $11,600 as of December 31, 2014.

Accounts Receivables and Allowance

Our trade accounts receivables are recorded at invoiced amounts and do not bear interest. We record an allowance for doubtful accounts against our trade receivables to reflect the balance at net realizable value on our consolidated balance sheets.

An allowance for doubtful accounts is established for accounts receivable estimated to be uncollectible due to client credit worthiness and is adjusted periodically based upon management’s evaluation of current economic conditions, historical experience and other relevant factors that, in the opinion of management, deserve recognition in estimating such allowance. Estimates related to our allowance for doubtful accounts are recorded as bad debt expense in our consolidated statement of operations. We review our allowance for doubtful accounts based upon the credit risk of specific clients, historical experience and other information.

Client Service Allowance

We maintain a client service allowance based on management’s evaluation of historical experience, current trends, individual client experience and other relevant factors that, in the opinion of management, deserve recognition in estimating such allowance. Estimates related to our client service allowance are recorded as a reduction to net revenue in our consolidated statements of operations and as a current liability in our consolidated balance sheets.

Financial Instruments

The carrying amount reported on the balance sheet for trade accounts receivable, trade accounts payable, accrued revenue share obligations and rebates, accrued payroll and benefits, and other accrued expenses approximate fair values due to the short maturities of the financial instruments.

We believe the carrying amount of notes payable approximates fair value since they bear interest at variable rates, and interest expense is accrued on notes outstanding. The current portion of notes payable represents the portion of notes payable due within one year of the period end.

The fair value of the bonds payable is calculated based on quoted market prices for the same or similar issues or on rates currently offered to the Company for similar debt instruments.

Revenue Recognition

Net revenue consists primarily of: (a) administrative fees reported under contracts with manufacturers and distributors and (b) other service fee revenue that is comprised of: (i) consulting revenues received under fixed-fee or contingent-based service contracts; (ii) subscription and implementation fees received under our software as a service (“SaaS”) agreements; and (iii) transaction and contingent fees received under service contracts. Revenue is earned primarily in the United States and to a limited extent, Canada.

Revenue is recognized when: 1) there is persuasive evidence of an arrangement; 2) the fee is fixed or determinable; 3) services have been rendered and payment has been contractually earned, and 4) collectability is reasonably assured.

Administrative Fees

Administrative fees are generated under contracted purchasing agreements with manufacturers and distributors of healthcare products and services (“vendors”). Vendors pay administrative fees to us in return for the provision of aggregated sales volumes from hospitals and health systems that purchase products qualified under our contracts. The administrative fees paid to us represent a percentage of the purchase volume of our hospitals and healthcare system clients.

We earn administrative fees in the quarter in which the respective vendors report client purchasing data to us, usually a month or a quarter in arrears of actual client purchase activity. The majority of our vendor contracts disallow netting product returns from the vendors’ administrative fee calculations in periods subsequent to their reporting dates. For those contracts that allow for netting of product returns, vendors supply us with sufficient purchase and return data needed for us to estimate and record an allowance for sales returns.

Revenue is recognized upon the receipt of vendor reports as this reporting proves that the delivery of the product or service has occurred, the administrative fees are fixed and determinable based on reported purchasing volume, and collectability is reasonably assured. Our client and vendor contracts substantiate persuasive evidence of an arrangement.

Certain hospital and healthcare system clients receive a revenue share obligation. This obligation is recognized according to the clients’ contractual agreements with our group purchasing organization (“GPO”) as the related administrative fee revenue is recognized. In accordance with GAAP relating to principal agent considerations under revenue recognition, this obligation is netted against the related gross administrative fees, and is presented on the accompanying consolidated statements of operations as a reduction to arrive at total net revenue on our consolidated statements of operations.

Net administrative fees shown on our consolidated statements of operations reflect our gross administrative fees net of our revenue share obligation. Gross administrative fees include all administrative fees we receive pursuant to our GPO vendor contracts. Our revenue share obligation represents the portion of the administrative fees we are contractually obligated to share with certain of our GPO clients. The following shows the details of net administrative fee revenues for the years ended December 31, 2014, 2013 and 2012:

Year Ended December 31,

2014

2013

2012

Gross administration fees

494,927

472,113

427,698

Less: Revenue share obligation

(203,564

)

(182,638

)

(160,783

)

Administrative fees, net

291,363

289,475

266,915

Other Service Fees

Consulting Fees

We generate revenue from fixed-fee consulting contracts. Revenue under these fixed-fee arrangements is recognized based on a proportional performance method as services are performed and deliverables are provided, as long as all other elements of SAB 104 are met.

Consulting Fees with Performance Targets

We generate revenue from consulting contracts that also include performance targets. The performance targets generally relate to committed financial improvement to our clients from the use and implementation of initiatives that result from our consulting services. Performance targets are measured as our strategic initiatives are identified and implemented, and the financial improvement can be quantified by the client. In the event the performance targets are not achieved, we are obligated to refund or reduce a portion of our fees.

Under these arrangements, all revenue is deferred and recognized as the performance target is achieved and the applicable contingency is released as evidenced by client acceptance. All revenues are fixed and determinable and the applicable service is rendered prior to recognition in the financial statements in accordance with SAB 104. One-time or non-recurring performance fees are recognized proportionately over the contract term in the period in which they are earned. We do not defer any related costs under these types of arrangements.

Subscription and Implementation Fees

We follow GAAP for revenue recognition relating to arrangements that include the right to use software stored on another entity’s hardware for our SaaS-based solutions. Our clients are typically charged upfront non-refundable fees for implementation and recurring host subscription fees for access to web-based services. Our clients have access to our software applications while the data is hosted and maintained on our servers. Our clients cannot take physical possession of the software applications. Revenue from monthly hosting arrangements and services is recognized on a subscription basis over the period in which our clients have access to the product. Implementation fees are typically billed at the beginning of the arrangement and recognized as revenue over the greater of the subscription period or the estimated client relationship period beginning at client acceptance. We currently estimate the client relationship period at six years for our SaaS-based Revenue Cycle Management solutions. Contract subscription periods generally range from two to six years from execution.

Transaction Fees and Contingent Service Fees

We generate revenue from transactional-based service contracts and contingency-fee based service contracts. Provided all other elements of revenue recognition are met, revenue under these arrangements is recognized as services are performed, deliverables are provided and related contingencies are removed. All related direct costs are recorded as period costs when incurred.

Other

Other fees are primarily earned for our annual client and vendor meeting. Fees for our annual client and vendor meeting are recognized when the meeting is held and related obligations are performed.

Revenue Recognition — Multiple-Deliverable Revenue Arrangements

Effective January 1, 2011, we adopted the FASB’s accounting standards update for multiple-deliverable arrangements on a prospective basis. The guidance establishes a selling price hierarchy for determining the appropriate value of a deliverable. The hierarchy is based on: (a) vendor-specific objective evidence, if available (“VSOE”); (b) third-party evidence (“TPE”) if vendor-specific objective evidence is not available; or (c) estimated selling price (“ESP”) if neither VSOE nor TPE is available. The guidance also eliminates the residual method of allocation of contract consideration to elements in the arrangement and requires that arrangement consideration be allocated to all elements at the inception of the arrangement using the relative selling price method.

Based on the selling price hierarchy established by the update, if we are unable to establish selling price using VSOE or TPE, we will establish an ESP. ESP is the estimated price at which we would transact a sale if the product or service were sold on a stand-alone basis. We establish a best estimate of ESP considering internal factors relevant to pricing practices such as costs and margin objectives, standalone sales prices of similar services and percentage of the fee charged for a primary service relative to a related service. Additional consideration is also given to market conditions such as competitor pricing strategies and other factors such as market size, the number of facilities, and the number of beds in a facility. If available, we regularly review VSOE and TPE for our services in addition to ESP.

Our revenue recognition policy for multiple-deliverable revenue arrangements is as follows:

We may bundle certain of our SCM service and technology offerings into a single service arrangement. We may also bundle certain of our RCM service and technology offerings into a single service arrangement. In addition, we may bundle certain of both of our SCM and RCM service and technology offerings together into a single service arrangement and market them as an enterprise arrangement.

Service arrangements generally include multiple deliverables or elements such as group purchasing services, consulting services, and SaaS-based subscription and implementation services. Provided that the total arrangement consideration is fixed and determinable at the inception of the arrangement, we allocate the total arrangement consideration to the individual elements within the arrangement based on their relative selling price using VSOE, TPE, or ESP for each element of the arrangement. We establish VSOE, TPE, or ESP for each element of a service arrangement based on the price charged for a particular element when it is sold separately in a stand-alone arrangement. Revenue is then recognized for each element according to the following revenue recognition methodology: (i) group purchasing service revenue is recognized as administrative fees are reported to us (generally approximates ratable recognition over the contractual term); (ii) consulting revenue is recognized on a proportional performance method as services are performed and deliverables are provided or once performance targets are accepted by our clients; and (iii) SaaS-based subscription revenue is recognized ratably over the subscription period (upfront non-refundable fees on our SaaS-based subscription services are recognized over the longer of the subscription period or the estimated client relationship period) beginning with the period in which the SaaS-based services are accepted by the client.

The majority of our multi-element service arrangements that include group purchasing services are not fixed and determinable at the inception of the arrangement because the fees for such arrangements are earned as administrative fees are reported. Administrative fees are not fixed and determinable until the receipt of vendor reports. For these multi-element service arrangements, we recognize each element as such element is delivered and as administrative fees are reported to us which generally approximates ratable recognition over the contract term.

In addition, certain of our arrangements include performance targets or other contingent fees that are not fixed and determinable at the inception of the arrangement. If the total arrangement consideration is not fixed and determinable at the inception of the arrangement, we allocate only that portion of the arrangement that is fixed and determinable to each element. As additional consideration becomes fixed, it is similarly allocated based on VSOE, TPE or ESP to each element in the arrangement and recognized in accordance with each element’s revenue recognition policy.

Performance targets generally relate to committed financial improvement to our clients from the use of our services. Revenue is only recognized if there are no refund rights and the fees earned are fixed and determinable. We obtain client acceptance as performance targets are achieved. In the event the performance targets are not achieved, we may be obligated to refund or reduce a portion of our fees and as such do not consider these fees fixed and determinable until we receive client acceptance.

In multi-element service arrangements that involve performance targets, the amount of revenue recognized on a particular delivered element is limited to the amount of revenue earned based on: (i) the proportionate performance of the individual element compared with all elements in the arrangement using the relative selling price method; and (ii) the proportional performance of that individual element. In all cases, revenue recognition is deferred on each element until the contingency on the performance target has been removed and the related revenue is fixed and determinable.

Deferred Costs

We capitalize direct costs incurred during the implementation of our SaaS-based solutions. Deferred implementation costs are amortized into cost of revenue in proportion to the revenue earned over the client relationship period. In addition, we defer upfront sales commissions primarily related to subscription and implementation fees and expense these costs ratably over the contract term. The current and long term portions of deferred costs are included in “Prepaid expense and other current assets” and “Other assets,” respectively in the accompanying consolidated balance sheets.

Property and Equipment

Property and equipment are stated at cost and include the capitalized portion of internal use product development costs. Depreciation of property and equipment (which includes amortization of capitalized internal use software) is computed on the straight-line method over the estimated useful lives of the assets which are as follows:

Useful Lives

(in years)

Buildings

Furniture and fixtures

Computers and equipment

7-May

Leasehold improvements

Term of lease

Purchased software and capitalized software development costs (internal use)

5-Mar

We evaluate the impairment or disposal of our property and equipment in accordance with GAAP. We evaluate the recoverability of property and equipment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable, or whenever management has committed to an asset disposal plan. Whenever these indicators occur, recoverability is determined by comparing the net carrying value of an asset to its total undiscounted cash flows.

Product Development Costs

Our product development costs include costs incurred: (i) prior to the application development stage; (ii) prior to technological feasibility being reached; and (iii) in the post-development or maintenance stage. The majority of our software development costs relate to internal-use software development costs which are capitalized in accordance with relevant GAAP and classified as property and equipment. We have a small amount of external-use software development costs which are capitalized when the technological feasibility of a software product has been established in accordance with GAAP relating to research and development costs of computer software and are included in “Other” within Other long term assets in the accompanying consolidated balance sheets. Capitalized software costs are amortized on a straight-line basis over the estimated useful lives of the related software applications of up to five years. We periodically evaluate the useful lives of our capitalized software costs.

Goodwill and Intangible Assets — Indefinite Life

For identified intangible assets acquired in business combinations, we allocate purchase consideration based on the fair value of intangible assets acquired in accordance with GAAP relating to business combinations.

As of December 31, 2014 and 2013, intangible assets with indefinite lives consist of goodwill. See Note 3 for further details.

We account for our intangible assets in accordance with GAAP relating to intangible assets, which states that goodwill or intangible assets with indefinite lives are not amortized. Our annual impairment testing date is October 1. We perform an impairment test of these assets on at least an annual basis and whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. To determine the fair values, we use the income approach based on estimated discounted future cash flows and the market approach based on comparable publicly traded companies in similar lines of business, and to a lesser extent, guideline public companies. Our cash flow assumptions consider historical and forecasted revenue, operating costs and other relevant factors. If the carrying value of the assets is deemed to be impaired, the amount of the impairment recognized in the financial statements is determined by estimating the fair value of the assets and recording a loss for the amount that the carrying value exceeds the estimated fair value.

We consider the following to be important factors that could trigger an impairment review: significant continued underperformance relative to historical or projected future operating results; identification of other impaired assets within a reporting unit; the more-likely-than not expectation that a reporting unit or a significant portion of a reporting unit will be sold; significant adverse changes in business climate or regulations; significant changes in senior management; significant changes in the manner of use of the acquired assets or the strategy for the Company’s overall business; significant negative industry or economic trends; a significant decline in the Company’s stock price for a sustained period or a significant unforeseen decline in the Company’s credit rating.

In connection with our 2014 annual impairment testing, we recognized an impairment charge of $52,539 on the goodwill relating to our revenue cycle services operating unit which is part of our Revenue Cycle Management reporting segment. We did not recognize any goodwill or indefinite-lived intangible asset impairments during the fiscal years ended December 31, 2013 and 2012.

Intangible Assets — Definite Life

The intangible assets with definite lives are comprised of our customer base, developed technology, non-compete agreements and certain trade name assets. See Note 4 for further details.

Intangible assets with definite lives are amortized over their estimated useful lives which have been derived based on an assessment of such factors as attrition, expected volume and price changes. We evaluate the useful lives of our intangible assets with definite lives on an annual basis. Costs related to our customer base are amortized over the period and pattern of economic benefit that is expected from the client relationship based on the expected benefit of discounted cash flows. Customer base intangibles have estimated useful lives that range from seven to fourteen years. Costs related to developed technology are amortized on a straight-line basis over a useful life of three to seven years. Costs related to non-compete agreements are amortized on a straight-line basis over the life of the respective agreements. Costs associated with definite-lived trade names are amortized over the period of expected benefit of two to three years.

We evaluate indefinite-lived intangibles for impairment when events or changes in circumstances indicate that the carrying value of such assets may not be recoverable.

Business Combinations

We account for acquisitions in accordance with GAAP relating to business combinations. The guidance requires recognition of assets acquired, liabilities assumed, and contingent consideration at their fair value on theacquisition date with subsequent changes recognized in earnings; requires acquisition related expenses and restructuring costs to be recognized separately from the business combination and expensed as incurred; requires in-process research and development to be capitalized at fair value as an indefinite-lived intangible asset until completion or abandonment; and requires that changes in accounting for deferred tax asset valuation allowances and acquired income tax uncertainties after the measurement period be recognized as a component of provision for taxes. While we use our best estimates and assumptions as a part of the purchase price allocation process to accurately value assets acquired and liabilities assumed as of the business combination date, our estimates and assumptions are inherently uncertain and subject to refinement. As a result, during the preliminary purchase price measurement period, which may be up to one year from the business combination date, we record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. After the preliminary purchase price measurement period, we record adjustments to assets acquired or liabilities assumed subsequent to the purchase price measurement period in our operating results in the period in which the adjustments were determined.

Restructuring, Acquisition and Integration — Related Expenses

Restructuring, acquisition and integration-related expenses may consist of: (i) transaction costs incurred to complete acquisitions including due diligence, consulting and other advisory related fees; (ii) integration-related costs related to third party consulting and other employee-related costs associated with the integration of an acquired business into our business; (iii) acquisition-related fees associated with unsuccessful acquisition attempts; and (iv) restructuring-related costs. Our restructuring-related costs are comprised primarily of employee termination costs related to headcount reductions. A liability for costs associated with an exit or disposal activity is recognized and measured initially at fair value only when the liability is incurred. Our restructuring charges also include accruals for estimated losses related to our excess facilities, based on our contractual obligations, net of estimated sublease income. We reassess the liability periodically based on market conditions. Refer to Note 5 for additional details of restructuring activities.

Deferred Revenue

Deferred revenue consists of unrecognized revenue related to advanced client invoicing or client payments received prior to revenue being realized and earned. Substantially all deferred revenue consists of: (i) deferred administrative fees; (ii) deferred service fees; (iii) deferred software and implementation fees; and (iv) other deferred fees, including receipts for our annual client and vendor meeting prior to the event.

Deferred administrative fees arise when cash is received from vendors prior to the receipt of vendor reports. Vendor reports provide details about a client’s purchases and provide evidence that delivery of product or service occurred. Administrative fees are also deferred when reported fees are contingent upon meeting a performance target that has not yet been achieved.

Deferred service fees arise when cash is received from clients or upon advanced client invoicing, prior to delivery of service. When the fees are contingent upon meeting a performance target that has not yet been achieved, the service fees are either not invoiced or are deferred on our balance sheet.

Deferred software and implementation fees primarily include: (i) implementation fees that are received at the beginning of a subscription contract. These fees are deferred and amortized over the expected period of benefit, which is the greater of the contracted subscription period or the client relationship period; and to a lesser extent, (ii) software support fees which represent client payments made in advance for annual software support contracts. Software and implementation fees are also deferred when the fees are contingent upon meeting a performance target that has not yet been achieved.

For the years ended December 31, 2014 and 2013, deferred revenues recorded that are contingent upon meeting performance targets were $8,441 and $6,516, respectively.

The following table summarizes the deferred revenue categories and balances as of:

December 31,

2014

2013

Software and SaaS implementation fees

55,152

27,393

Service fees

19,241

22,363

Administrative fees

15,715

10,935

Other fees

1,344

2,201

Deferred revenue, total

91,452

62,892

Less: Deferred revenue, current portion

(76,034

)

(46,523

)

Deferred revenue, non-current portion

15,418

16,369

Revenue Share Obligation and Rebates

We accrue revenue share obligation and rebates for certain clients according to our: (i) revenue share program and (ii) vendor rebate program.

Under our revenue share program, certain hospital and health system clients receive revenue share payments. This obligation is accrued according to contractual agreements between our GPO and the hospital and healthcare clients as the related administrative fee revenue is recognized. See description of this accounting treatment under “Administrative Fees” in the “Revenue Recognition” section.

We receive rebates pursuant to the provisions of certain vendor agreements. The rebates are earned by our hospitals and health system clients based on the volume of their purchases. We collect, process, and pay the rebates as a service to our clients. Substantially all the vendor rebates are excluded from revenue. The vendor rebates are accrued for active clients when we receive cash payments from vendors.

Advertising Costs

Advertising costs are expensed as incurred. Advertising expense for the years ended December 31, 2014, 2013 and 2012 was $2,598, $3,196 and $2,750, respectively.

Defined Contribution Plan

We sponsor a defined contribution plan for eligible employees. Under the terms of the plan, employees have the option of contributing a portion of their annual salary to the plan. We make matching contributions of 50 cents for each dollar contributed by employees up to the first six percent of compensation contributed. For the years ended December 31, 2014, 2013 and 2012, our plan contributions amounted to $6,535, $6,062 and $5,175, respectively.

Share-Based Compensation

Share-based payment transactions (as fully discussed in Note 9) are accounted for in accordance with GAAP relating to stock compensation. The guidance requires companies to recognize the cost (expense) of all share-based payment transactions in the financial statements. We expense employee share-based compensation using fair value-based measurement over an appropriate requisite service period primarily on an accelerated basis.

Derivative Financial Instruments

Derivative instruments are accounted for in accordance with GAAP relating to derivatives and hedging. The guidance requires companies to recognize derivative instruments as either assets or liabilities on the balance sheet at fair value. See Note 13 for further discussion regarding our derivative financial instruments.

Income Taxes

In accordance with GAAP relating to income taxes, we recognize deferred income taxes based on the expected future tax consequences of differences between the financial statement basis and the tax basis of assets and liabilities, calculated using enacted tax rates in effect for the tax year in which the differences are expected to be reflected in the tax return.

The carrying value of our net deferred tax assets assumes that we will be able to generate sufficient future taxable income in applicable tax jurisdictions to realize the value of these assets. If we are unable to generate sufficient future taxable income in these jurisdictions, a valuation allowance is recorded when it is more likely than not that the value of the deferred tax assets is not realizable. Management evaluates the realizability of deferred tax assets and assesses the need for any valuation allowance adjustment. It is our policy to provide for uncertain tax positions and the related interest and penalties based upon management’s assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. To the extent that the tax outcome of these uncertain tax positions falls below more likely than not, the change in estimate will impact the income tax provision in the period in which such determination is made. At December 31, 2014, we believe we have appropriately accounted for any unrecognized tax benefits. To the extent we prevail in matters for which a liability for an unrecognized tax benefit is established or we are required to pay amounts in excess of the liability, our effective tax rate in a given financial statement period may be affected. See Note 10 for further information.

Sales Taxes

In accordance with GAAP relating to principal agent considerations under revenue recognition, we record any tax assessed by a governmental authority that is directly imposed on a revenue-producing transaction between a seller and a client on a net basis (excluded from revenues).

Basic and Diluted Net Income and Loss Per Share

Basic net income or (loss) per share (“EPS”) is calculated in accordance with GAAP relating to earnings per share. Diluted EPS assumes the conversion, exercise or issuance of all potential common stock equivalents, unless the effect of inclusion would result in the reduction of a loss or the increase in income per share. For purposes of this calculation, our stock options, stock warrants, non-vested restricted stock, stock-settled stock appreciation rights and shares that were purchasable pursuant to our employee stock purchase plan are considered to be potential common shares and are only included in the calculation of diluted EPS when the effect is dilutive.

The shares used to calculate basic and diluted EPS represent the weighted-average common shares outstanding. Diluted net (loss) per share is the same as basic net (loss) per share for the fiscal years ended December 31, 2014 and 2012 since the effect of any potentially dilutive securities was excluded (as they were anti-dilutive due to our net loss).

Comprehensive Income

Comprehensive income reflects the change in equity during the periods presented and is comprised of all components of net income and all components of other comprehensive income.

Recent Accounting Pronouncements

Going Concern

In August 2014, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update relating to disclosure of uncertainties about an entity’s ability to continue as a going concern. The update provides guidance about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures in the event that there is such substantial doubt. The update will be effective on January 1, 2016.

Share-Based Compensation

In June 2014, the FASB issued an accounting standard update relating to reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. This update requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The update will be effective on January 1, 2016.

Revenue Recognition

In May 2014, the FASB issued an accounting standard update relating to revenue from contracts with customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The update will replace most existing revenue recognition guidance under GAAP when it becomes effective. The update is effective for us on January 1, 2017. Early application is not permitted. The update permits the use of either the retrospective or cumulative effect transition method. We are evaluating the effect that the update will have on our consolidated financial statements and related disclosures. We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting.

Discontinued Operations

In April 2014, the FASB issued an accounting standard update which revises what qualifies as a discontinued operation, changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. This update will be effective for applicable transactions occurring after January 1, 2015.

Income Taxes

In July 2013, the FASB issued an accounting standard update relating to the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This update amends existing GAAP that required in certain cases, an unrecognized tax benefit, or portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward when such items exist in the same taxing jurisdiction. The amendments in this update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date, and retrospective application is permitted. We adopted this update on January 1, 2014.

Obligations Resulting from Joint and Several Liability Arrangements

In February 2013, the FASB issued guidance for the recognition, measurement and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of the guidance is fixed at the reporting date. Examples of obligations within the scope of this update include debt arrangements, other contractual obligations and settled litigation and judicial rulings. The guidance requires an entity to measure such obligations as the sum of the amount that the reporting entity agreed to pay on the basis of its arrangement among its co-obligors plus additional amounts the reporting entity expects to pay on behalf of its co-obligors. The guidance in the update also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations. The update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. We adopted this update on January 1, 2014.

Property_and_Equipment

Property and Equipment	12 Months Ended
Property and Equipment	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property and Equipment	2. PROPERTY AND EQUIPMENT

	Property and equipment consists of the following as of:



		December 31,
		2014			2013
	Land	$	1,200		$	1,200
	Buildings		8,821			8,821
	Furniture and fixtures		14,806			14,130
	Computers and equipment		65,006			58,710
	Leasehold improvements		21,904			20,700
	Purchased software		37,828			30,931
	Capitalized software development costs (internal use)		186,076			147,828

			335,641			282,320
	Accumulated depreciation and amortization		(165,323	)		(124,573	)

	Property and equipment, net	$	170,318		$	157,747


	We received a tenant allowance related to an operating lease entered into on March 1, 2013 amounting to $10,378 which was recorded as a leasehold improvement on our consolidated balance sheet. The leasehold improvement is being depreciated on a straight line basis over the term of the lease of fifteen years. We had approximately $9,110 and $9,802 included in property and equipment on our consolidated balance sheet as of December 31, 2014 and 2013, respectively.

	During the year ended December 31, 2014 and 2012, we had no impairment charges related to property and equipment.

	During the year ended December 31, 2013, we had impairment charges related to property and equipment of approximately $3,551.



	Software — Internal Use

	We classify capitalized costs of software developed for internal use in property and equipment. Costs capitalized for software to be sold, leased or otherwise marketed are classified as other assets. Software acquired in a business combination is classified as a developed technology intangible asset. Additions of capitalized costs of software developed for internal use during the years ended December 31, 2014 and 2013 amounted to $38,092 and $38,944, respectively. Accumulated amortization related to capitalized costs of software developed for internal use was $85,555 and $57,823 at December 31, 2014 and 2013, respectively.

	Software — External Use

	Capitalized costs of software developed for external use are classified as other assets on our consolidated balance sheet. Additions of capitalized costs of software developed for external use during the years ended December 31, 2014 and 2013 amounted to $3,429 and $4,399, respectively. Gross carrying value related to capitalized costs of software developed for external use was $23,263 and $19,834 at December 31, 2014 and 2013, respectively. Accumulated amortization related to capitalized costs of software developed for external use was $13,845 and $10,714 at December 31, 2014 and 2013, respectively.

	During the years ended December 31, 2014, 2013 and 2012, we recognized $3,131, $2,157 and $1,859, respectively, in cost of revenue related to amortization of software developed for external use.

Goodwill

Goodwill	12 Months Ended
Goodwill	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	3. GOODWILL
	Goodwill consists of the following as of:


		December 31,
		2014			2013
	Goodwill, net	$	1,058,414		$	1,027,847
	The changes in goodwill are summarized as follows, consolidated and by segment, for the years ended December 31, 2014 and 2013:


		December 31,
		Consolidated			SCM		RCM
	Balance, December 31, 2012 and 2013	$	1,027,847		$	645,202	$	382,645
	Sg2 acquisition (Note 5)		81,476			81,476		—
	TRG acquisition (Note 5)		1,630			1,630		—
	RCS impairment loss		(52,539	)		—		(52,539	)

	Balance, December 31, 2014	$	1,058,414		$	728,308	$	330,106
	In connection with our 2014 annual impairment testing, we recognized an impairment charge related to the goodwill at our revenue cycle services (“RCS”) operating unit within our RCM reporting segment. As part of our quarterly and annual forecasting process, we expect our future revenue growth to come from lower margin services. As a result, our projected margins within our discounted cash flow model used for impairment testing were therefore reduced, and the resulting business enterprise value could no longer support the amount of goodwill on the consolidated balance sheet related to the RCS operating unit. As a result, during the fourth quarter of 2014 we incurred a goodwill impairment charge within our RCM segment. We recorded a preliminary estimate of $52,539 related to the goodwill impairment charge. The goodwill impairment amount is preliminary pending receipt of our final valuation report.

	Further, as a result of our annual impairment test as of October 1, 2014, the estimated fair value of our SCM segment substantially exceeded its respective carrying value and the estimated fair value of our revenue cycle technology operating unit within our RCM segment exceeded its respective carrying value by more than 10%.

Other_Intangible_Assets

Other Intangible Assets	12 Months Ended
Other Intangible Assets	Dec. 31, 2014
Text Block [Abstract]
Other Intangible Assets	4. OTHER INTANGIBLE ASSETS

	Intangible assets with definite lives consist of the following:



			Weighted		Gross		Accumulated			Net
			Average		Carrying		Amortization
			Remaining		Amount
			Amortization
			Period
			(Years)(1)
	December 31, 2014
	Customer base			3 years	$	529,145	$	(287,187	)	$	241,958
	Developed technology			3 years		43,900		(12,375	)		31,525
	Trade name			2 years		1,100		(100	)		1,000
	Non-compete agreement			2 years		2,080		(156	)		1,924

				3 years	$	576,225	$	(299,818	)	$	276,407


	-1	The period represents the weighted average amortization period remaining in total and for each asset class.



			Weighted		Gross		Accumulated			Net
			Average		Carrying		Amortization
			Remaining		Amount
			Amortization
			Period
			(Years)(1)
	31-Dec-13
	Customer base			3 years	$	510,547	$	(248,094	)	$	262,453
	Developed technology			2 years		13,300		(8,313	)		4,987

				3 years	$	523,847	$	(256,407	)	$	267,440


	-1	The period represents the weighted average amortization period remaining in total and for each asset class.

	In 2014, we reduced the gross carrying amount and the related accumulated amortization of our intangible assets by approximately $14,200 relating to a fully amortized customer base asset within our RCM segment.

	In 2013, we reduced the gross carrying amount and the related accumulated amortization of our intangible assets by the following: (i) approximately $23,200 relating to fully amortized developed technology assets within our RCM segment; and (ii) approximately $4,300 relating to a fully amortized trade name within our SCM segment.

	During the years ended December 31, 2014, 2013 and 2012, we recognized $57,593, $62,723 and $73,209, respectively in amortization expense, inclusive of ($0, $0 and $557) charged to cost of revenue for amortization of external-use acquired developed technology related to definite-lived intangible assets. Future amortization expense of definite-lived intangibles as of December 31, 2014, is as follows:



			Amount
	2015		$	58,831
	2016			51,897
	2017			47,715
	2018			41,894
	2019			37,310
	Thereafter			38,760

			$	276,407

Restructuring_Acquisition_and_

Restructuring Acquisition and Integration-Related Expenses	12 Months Ended
Restructuring Acquisition and Integration-Related Expenses	Dec. 31, 2014
Text Block [Abstract]
Restructuring Acquisition and Integration-Related Expenses	5. RESTRUCTURING, ACQUISITION AND INTEGRATION-RELATED EXPENSES
	Restructuring Activities
	Restructuring charges consist of exit costs and other costs associated with the reorganization of our operations, including employee termination costs, lease contract termination costs, impairment of assets, and any other qualifying exit costs. Costs associated with exit or disposal activities are generally recorded when the liability is incurred.
	In 2014, our management approved and initiated a plan to restructure our operations resulting in certain workforce changes within the Company that resulted in costs of approximately $4,207. During the fiscal years ended December 31, 2014, 2013 and 2012, we expensed restructuring and exit and integration-related costs of $4,207, $10,070 and $6,348, respectively. These costs are included within the restructuring, acquisition and integration-related expenses line on the accompanying consolidated statements of operations. As of December 31, 2014, cash payments were made of approximately $2,909 and we had approximately $1,918 included in current liabilities for these employee-related costs that we expect to pay over the next twelve months.
	Acquisition Activities
	Sg2 Acquisition
	On September 22, 2014, we acquired one hundred percent of the issued and outstanding equity interests (the “Membership Interests”) of SG-2, LLC (“Sg2”) for approximately $138,201 (subject to certain purchase price adjustments) (the “Sg2 Acquisition”). We funded the Sg2 Acquisition with cash on hand and borrowings under our existing credit facility. In December 2014, we reached an agreement on the final purchase price with the sellers of Sg2 to reflect the final working capital adjustment as defined by the purchase agreement. As a result, we recorded a decrease to the purchase price of approximately $32.
	Sg2 is a leading provider of healthcare market intelligence, strategic analytics and clinical consulting services to more than 1,500 hospitals and health systems, as well as pharmaceutical and medical device companies, understand current and future market dynamics in order to capitalize on growth and performance improvement opportunities.
	The purchase price paid for Sg2 and the resulting goodwill of $81,476 reflects a premium relative to the value of identified assets due to the strategic importance of the transaction to us and because Sg2’s business model does not rely intensively on fixed assets.

	We expect that all of the goodwill and identified intangible assets will be deductible for income tax purposes.
	Sg2 Purchase Price Allocation
	The following table summarizes the consideration paid for Sg2 and the preliminary amounts of the assets acquired and liabilities assumed recognized at the acquisition date:


	Fair value of total consideration transferred		$	138,201

	Recognized amounts of identifiable assets acquired and liabilities assumed
	Current assets		$	11,090
	Property and equipment			2,559
	Intangible assets			65,700
	Current liabilities			(21,849	)
	Long-term liabilities			(775	)

	Total identifiable net assets			56,725
	Goodwill			81,476

			$	138,201

	The fair value of current assets acquired includes trade accounts receivable due under agreements with customers with a fair value of approximately $9,198. The gross amount due under customer contracts is $9,598, of which $400 is expected to be uncollectible.
	Included in the purchase price allocation are the fair value of acquired identified intangible assets of $65,700, the fair value of which was primarily determined by applying the income approach, using several significant unobservable inputs for projected cash flows and a discount rate. These inputs are considered Level 3 inputs under the fair value measurements and disclosure guidance. The fair value of acquired identified intangible assets of $65,700 is preliminary pending receipt of final valuations for those assets. Our preliminary fair value estimates are as follows:


			Preliminary				Weighted-
			Estimated				average
			fair value				useful lives
	Customer base		$	32,300				11 year life
	Developed technology			30,600				6 year life
	Tradename			1,100				3 year life
	Non-compete agreement			1,700				3 year life

	Total acquired identified intangibles		$	65,700
	Also included in the purchase price allocation is the estimated fair value of the service obligation related to our commitment to provide continued SaaS-based software for Sg2 customer relationships that existed prior to the Sg2 Acquisition where the requisite service period has not yet expired. The estimated fair value of the obligation and other future services was determined utilizing a top-down approach. The top-down approach relies on market indicators of expected revenue for any obligation yet to be delivered with appropriate adjustments. Conceptually, we start with the amount we would expect to receive in a transaction, less primarily the estimated selling effort, which has already been performed, including an estimated profit margin on that selling effort. As a result of allocating the acquisition purchase price, we recorded an adjustment to reduce the carrying value of Sg2’s September 22, 2014 deferred revenue by $1,923 down to $17,901, an amount representing our estimate of the fair value of the service obligation assumed.
	The fair value of long-term liabilities relates to our determination that the terms of the acquired lease arrangement between Sg2 and the lessor were unfavorable relative to market prices. As a result, we valued and recorded an unfavorable lease obligation of approximately $995 (the short-term portion of approximately $220 is included in current liabilities).
	In connection with the Sg2 Acquisition, we incurred approximately $3,305 of costs primarily related to legal, financial, and accounting professional advisors. These costs were expensed as incurred and are included in the restructuring, acquisition and integration-related line item on the accompanying consolidated statement of operations.
	The operating results of Sg2 have been included in our consolidated statement of operations within our Spend and Clinical Resource Management (“SCM”) reporting segment since the September 22, 2014 acquisition date. Sg2 contributed revenues of $11,730 and a net loss of $2,408 from the date of acquisition through December 31, 2014.
	Unaudited Pro Forma Financial Information
	The unaudited financial information in the table below summarizes the combined results of operations of MedAssets and Sg2 on a pro forma basis. The pro forma information is presented as if the companies had been combined on January 1, 2013. The 2014 and 2013 pro forma results include the following non-recurring pro forma adjustments that were directly attributable to the Sg2 Acquisition:

		•		adjustments to reduce net revenue by approximately $2,019 during the fiscal year ended December 31, 2013, respectively, related to purchase accounting adjustments that reflect the fair value of the deferred revenue acquired;

		•		adjustments to exclude approximately $3,661 during the fiscal year ended December 31, 2014 of certain non-recurring expenses related to one-time special employee bonuses paid by Sg2 in connection with the Sg2 Acquisition. The supplemental pro forma earnings for the fiscal year ended December 31, 2013 were adjusted to include this charge; and

		•		adjustments to exclude approximately $3,305 during the fiscal year ended December 31, 2014 of certain non-recurring expenses in connection with the Sg2 Acquisition primarily related to legal, financial, and accounting professional advisors. The supplemental pro forma earnings for the fiscal year ended December 31, 2013 were adjusted to include these charges.

	The following pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the Sg2 Acquisition had taken place at the beginning of each period:


			Pro forma
			Year Ended December 31,
			2014				2013
	Net revenue		$	752,117			$	715,709
	Net (loss) income			(24,225	)			15,473
	Basic net (loss) income per share		$	(0.41	)		$	0.26
Diluted net (loss) income per share		$	(0.41	)		$	0.25
Basic weighted average shares			59,811				59,705
Diluted weighted average shares			59,811				61,178
Other Acquisition-Related Activities
During the fiscal year ended December 31, 2014, our SCM segment acquired certain assets associated with hospital and physician consultative solutions for $3,055. The acquired assets consisted of current assets of $565, a customer base valued at $480 with a three-year weighted-average useful life, a non-compete intangible asset valued at $380 with a three-year weighted-average useful life and goodwill of $1,630, all of which will be deductible for income tax purposes.

Notes_and_Bonds_Payable

Notes and Bonds Payable	12 Months Ended
Notes and Bonds Payable	Dec. 31, 2014
Debt Disclosure [Abstract]
Notes and Bonds Payable	6. NOTES AND BONDS PAYABLE
	Our notes and bonds payable are summarized as follows as of:


			December 31,
			2014			2013
	Term A facility		$	225,000		$	237,500
	Term B facility			179,000			192,000
	Revolving credit facility			152,000			10,000

	Total notes payable			556,000			439,500
	Bonds payable			325,000			325,000

	Total notes and bonds payable			881,000			764,500
	Less: current portions			(29,583	)		(15,500	)

	Total long-term notes and bonds payable		$	851,417		$	749,000

	Notes Payable
	As of December 31, 2014, our long-term notes payable consists of a Term A Facility, a Term B Facility and a revolving credit facility under a credit agreement with JP Morgan Chase Bank, N.A and other financial institutions named therein, dated December 13, 2012 (as amended from time to time, the “Credit Agreement”), each with an outstanding balance of $225,000, $179,000 and $152,000, respectively. We have classified the $152,000 outstanding balance on our revolving credit facility as a long term liability given the maturity date of December 13, 2017. No amounts were drawn on our swing line loan, which resulted in $147,000 of availability under our revolving credit facility (after giving effect to $1,000 of outstanding but undrawn letters of credit on such date and the increase in the revolving credit facility as discussed below) as of December 31, 2014. During the fiscal year ended December 31, 2014, we made scheduled principal payments of $15,500 on our Term A Facility and Term B Facility in addition to $10,000 voluntary prepayment on our Term B Facility and $40,000 in voluntary payments on our revolving credit facility. The applicable weighted average interest rates (inclusive of the applicable bank margin) on our Term A Facility, Term B Facility and Revolving Credit Facility at December 31, 2014 were 2.49%, 4.00% and 2.48%, respectively. On September 8, 2014, the Company entered into a First Increase Joinder to the Credit Agreement (the “First Increase Joinder”). The First Increase Joinder increased the revolving commitment amount under the Credit Agreement by $100,000 to $300,000. In connection with the First Increase Joinder, we incurred and capitalized approximately $615 of debt issuance costs which will be amortized into interest expense ratably over the remaining term of the revolving credit facility.
	The Credit Agreement contains certain customary negative covenants, including but not limited to, limitations on the incurrence of debt, limitations on liens, limitations on fundamental changes, limitations on asset sales and sale leasebacks, limitations on investments, limitations on dividends or distributions on, or redemptions of, equity interests, limitations on prepayments or redemptions of unsecured or subordinated debt, limitations on negative pledge clauses, limitations on transactions with affiliates and limitations on changes to the Company’s fiscal year. The Credit Agreement also includes maintenance covenants of maximum ratios of consolidated total indebtedness (subject to certain adjustments) to consolidated EBITDA (subject to certain adjustments) and minimum cash interest coverage ratios. The Credit Agreement contains certain customary representations and warranties, affirmative covenants and events of default, including but not limited to, payment defaults, breaches of representations and warranties, covenant defaults, cross-defaults to certain indebtedness, certain events of insolvency or bankruptcy, material judgments, certain events under ERISA, actual or asserted failures of any guaranty or security document supporting the credit agreement to be in full force and effect and changes of control. The Company was in compliance with these covenants as of December 31, 2014. We are also required to prepay our debt obligations based on an excess cash flow calculation for the applicable fiscal year which is determined in accordance with the terms of the Credit Agreement. Our current portion of notes payable includes approximately $7,833 with respect to our 2014 required excess cash flow payment which will be paid within the first quarter of 2015.
	All of the Company’s obligations under the Credit Agreement are unconditionally guaranteed by each of the Company’s existing and subsequently acquired or organized wholly-owned restricted subsidiaries, except that the following subsidiaries do not and will not provide guarantees: (a) unrestricted subsidiaries, (b) subsidiaries with tangible assets and revenues each having a value of less than 2.5% of the consolidated tangible assets and consolidated revenues of the Company (provided that all such immaterial subsidiaries, on a consolidated basis, shall not account for more than 5.0% of the consolidated EBITDA of the Company), (c) any subsidiary prohibited by applicable law, rule or regulation from providing a guarantee or which would require governmental (including regulatory) consent or approval or which would result in adverse tax consequences and (d) not-for-profit subsidiaries.
	All of the Company’s obligations under the Credit Agreement are secured by substantially all of the Company’s assets and the assets of each guarantor (subject to certain exceptions), including but not limited to, (1) a perfected pledge of all of the equity securities of each direct wholly owned restricted subsidiary of the Company and of each subsidiary guarantor (which pledge, in the case of any foreign subsidiary, is limited to 65% of the equity securities of such foreign subsidiary) and (2) perfected security interests in, and mortgages on, substantially all tangible and intangible personal property and material fee-owned real property of the Company and each subsidiary guarantor (including but not limited to, accounts receivable, inventory, equipment, general intangibles (including contract rights), investment property, intellectual property, material intercompany notes and proceeds of the foregoing).

	Loans under the Credit Agreement must be prepaid under certain circumstances, including with proceeds from certain future debt issuances, asset sales and a portion of excess cash flow for the applicable fiscal year. Loans under the Credit Agreement may be voluntarily prepaid at any time, subject to customary LIBOR breakage costs.
	Bonds Payable
	The Company has an aggregate principal amount of $325,000 of Notes outstanding that have been registered under the Securities Act of 1933, as amended. The Notes are guaranteed on a senior unsecured basis by each of our existing domestic subsidiaries and each of our future domestic restricted subsidiaries in each case that guarantees our obligations under the Credit Agreement. Each of the subsidiary guarantors is 100% owned by us. The guarantees by the subsidiary guarantors are full and unconditional. The guarantees by the subsidiary guarantors are joint and several. We have no independent assets or operations, and any subsidiaries of ours other than the subsidiary guarantors are minor. The Notes and the guarantees are senior unsecured obligations of the Company and the subsidiary guarantors, respectively.
	The Notes were issued pursuant to an indenture dated as of November 16, 2010 (the “Indenture”) among the Company, its subsidiary guarantors and Wells Fargo Bank, N.A., as trustee. Pursuant to the Indenture, the Notes will mature on November 15, 2018 and bear 8% annual interest. Interest on the Notes is payable semi-annually in arrears on May 15 and November 15 of each year, beginning on May 15, 2011.
	The Indenture contains certain customary negative covenants, including but not limited to, limitations on the incurrence of debt, limitations on liens, limitations on consolidations or mergers, limitations on asset sales, limitations on certain restricted payments and limitations on transactions with affiliates. The Indenture does not contain any significant restrictions on the ability of the Company or any subsidiary guarantor to obtain funds from the Company or any other subsidiary guarantor by dividend or loan. The Indenture also contains customary events of default. The Company was in compliance with these covenants as of December 31, 2014.
	The Company has the option to redeem all or a part of the Notes, at the following redemption prices:


	Year		Percentage
	2014			104	%
	2015			102	%
	2016 and thereafter			100	%
	The Notes also contain a redemption feature that would require the repurchase of 101% of the aggregate principal amount plus accrued and unpaid interest at the option of the holders upon a change in control.
	As of December 31, 2014, the Company’s 8% senior notes due 2018 were trading at 103.0% of par value (Level 1).
	Debt Issuance Costs
	As of December 31, 2014, we had approximately $14,075 of debt issuance costs related to our Credit Agreement and Notes which will be amortized into interest expense generally using the effective interest method until the applicable maturity date. For the fiscal year ended December 31, 2014, we recognized $3,805 in interest expense related to the amortization of debt issuance costs. For the fiscal year ended December 31, 2013, we recognized $3,807 in interest expense related to the amortization of debt issuance costs.

	Debt Maturity Table
	The following table summarizes our stated debt maturities and scheduled principal repayments as of December 31, 2014:


	Year		Term A Facility			Term B Facility(2)			Revolving		Senior		Total
									Credit Facility		Unsecured
											Notes
	2015(1)		$	23,112		$	6,471		$	—	$	—	$	29,583
	2016			25,000			3,000			—		—		28,000
	2017			176,888			3,000			152,000		—		331,888
	2018			—			3,000			—		325,000		328,000
	2019			—			163,529			—		—		163,529

			$	225,000		$	179,000		$	152,000	$	325,000	$	881,000


	-1	Includes mandatory 2014 excess flow payment of $7,833 payable during the first quarter of 2015.
	-2	The Term B Facility matures on December 13, 2019; however, the facility will mature in full on May 15, 2018 if our outstanding senior notes have not been repaid or refinanced in full by such date.
	Total interest paid (net of amounts capitalized) on our notes and bonds payable during the fiscal years ended December 31, 2014 and 2013 was approximately $41,464 and $45,185, respectively.
	Finance Obligation
	We are a party to a lease agreement for a certain office building in Cape Girardeau, Missouri (the “Lease Agreement”) in which we have continuing involvement as defined by GAAP relating to leases and as such recorded the transaction as a financing obligation.
	The lease payments on the office building are charged to interest expense in the periods they are due. The lease payments included as interest expense in the accompanying statement of operations for the years ended December 31, 2014, 2013 and 2012 were $676. The amount of the financial obligation decretion for the years ended December 31, 2014 and 2013 was $267 and $243, respectively.
	Rental income and additional interest expense is imputed under the Lease Agreement and amounts to approximately $438 annually. Both the income and the expense are included in “Other income (expense)” in the accompanying consolidated statement of operations for each of the years ended December 31, 2014, 2013 and 2012 with no effect to net income.
When we have no further continuing involvement with the building as defined under GAAP relating to leases, we will remove the net book value of the office building, adjoining retail space, and the related finance obligation and account for the remainder of our payments under the Lease Agreement as an operating lease. Under the Lease Agreement, we will not obtain title to the office building and retail space. Our future commitment is limited to the payments required by the Lease Agreement. At December 31, 2014, the future undiscounted payments under the Lease Agreement aggregate to $1,746.

Future payments of the finance obligation as of December 31, 2014 are as follows:


		Obligations
		Under
		Capital
		Lease
2015		$	1,114
2016			1,114
2017			8,600

			10,828
Less: Amounts representing interest			(2,059	)

Net present value of capital lease obligation			8,769
Less: Amount representing current portion			(294	)

Finance obligation, less current portion		$	8,475

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	7. COMMITMENTS AND CONTINGENCIES
	We lease certain office space and office equipment under operating leases. Some of our operating leases include rent escalations, rent holidays, and rent concessions and incentives. However, we recognize lease expense on a straight-line basis over the related minimum lease term utilizing total future minimum lease payments. Future minimum rental payments under operating leases with initial or remaining non-cancelable lease terms of one year or more as of December 31, 2014 are as follows:


		Operating
		Lease
	2015	$	13,342
	2016		8,651
	2017		8,956
	2018		9,962
	2019		8,855
	Thereafter		69,796

		$	119,562

	Rent expense for the years ended December 31, 2014, 2013 and 2012, was approximately $11,685, $16,635 and $11,060, respectively. Rent expense for the year ended December 31, 2013 included approximately $5,341 of lease termination fees related to the exit of certain facility leases. These lease termination fees are included in the restructuring, acquisition and integration-related expenses line item of the accompanying consolidated statements of operations.
	Performance Targets
	In the ordinary course of contracting with our clients, we may agree to make some or all of our fees contingent upon the client’s achievement of financial improvement targets from the use of our services and software. These contingent fees are not recognized as revenue until the client confirms achievement of the performance targets. We generally receive client acceptance as and when the performance targets are achieved. Prior to client confirmation that a performance target has been achieved, we record invoiced contingent fees as deferred revenue on our consolidated balance sheet. Often, recognition of this revenue occurs in periods subsequent to the recognition of the associated costs.

	Legal Proceedings
	As of December 31, 2014, we are not presently involved in any legal proceedings, the outcome of which, if determined adversely to us, would have a material adverse effect on our business, operating results or financial condition.

Stockholders_Equity

Stockholders' Equity

12 Months Ended

Dec. 31, 2014

Equity [Abstract]

Stockholders' Equity

8. STOCKHOLDERS’ EQUITY

Preferred Stock

In connection with our initial public offering we amended and restated our Certificate of Incorporation authorizing us to issue 50,000,000 shares of undesignated preferred stock, par value $0.01 per share. The preferred stock may be issued from time to time in one or more series, each series of which would have distinctive designation or title and such number of shares as was fixed by the Board prior to the issuance of any shares thereof. Each such series of preferred stock would have voting powers, full or limited, or no voting powers, and such preferences and relative, participating optional or other special rights and such qualifications, limitations or restrictions thereof, as stated and expressed in the resolution or resolutions providing for the issue of such series of preferred stock. We had no preferred stock issued or outstanding as of December 31, 2014 or 2013.

Common Stock

During 2014, 2013 and 2012, we issued shares of common stock in connection with employee share-based payment arrangements. See Note 9 for further information.

Common Stock Warrants

During the fiscal year ended December 31, 2013, approximately 13,000 shares of common stock were issued in connection with an exercise of warrants. As a result, as of December 31, 2014 and 2013, we had no warrants outstanding.

Repurchase of Common Stock

On February 26, 2014, our Board of Directors authorized a share repurchase program of up to $75,000 of our common stock. The table below shows the amount and cost of shares of common stock we repurchased for the fiscal year ended December 31, 2014 under the share repurchase program. The repurchased shares have not been retired and constitute authorized but unissued shares.

On August 23, 2011, our Board of Directors authorized a share repurchase program of up to $25,000 of our common stock. The table below shows the amount and cost of shares of common stock we repurchased for the fiscal year ended December 31, 2012 under the share repurchase program. The repurchased shares have not been retired and constitute authorized but unissued shares. The share repurchase program expired in August 2012.

December 31,

2014

2013

2012

Number of shares repurchased

1,784,645

—

62,334

Cost of shares repurchased

42,771

—

600

ShareBased_Compensation

Share-Based Compensation	12 Months Ended
Share-Based Compensation	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Compensation	9. SHARE-BASED COMPENSATION
	As of December 31, 2014, we had restricted common stock, restricted stock units (“RSUs”), stock-settled stock appreciation rights (or “SSARs”) and common stock option equity awards outstanding under three share-based compensation plans.
	The share-based compensation cost related to equity awards that has been charged against income was $17,849, $14,496 and $10,291 for the fiscal years ended December 31, 2014, 2013 and 2012, respectively. The total income tax benefit recognized in the income statement for share based compensation arrangements related to equity awards was $6,665, $5,365 and $3,853 for the fiscal years ended December 31, 2014, 2013 and 2012, respectively. There were no capitalized share-based compensation costs as of December 31, 2014, 2013 or 2012.
	Total share-based compensation expense (inclusive of restricted common stock, RSUs, common stock options, and SSARs) for the fiscal years ended December 31, 2014, 2013 and 2012 is reflected in our consolidated statements of operations as noted below:


			December 31,
			2014				2013			2012
	Cost of revenue		$	5,510			$	3,866		$	2,165
	Product development			954				635			181
	Selling and marketing			2,622				2,251			1,489
	General and administrative			8,763				7,744			6,456

	Total share-based compensation expense		$	17,849			$	14,496		$	10,291
	Employee Stock Purchase Plan
	In 2010, the Company established the MedAssets, Inc. Employee Stock Purchase Plan (the “ESPP Plan”). Under the ESPP Plan, eligible employees may purchase shares of our common stock at a discounted price through payroll deductions. The price per share of the common stock sold to participating employees will be 95% of the fair market value of such share on the applicable purchase date. The ESPP Plan requires that all stock purchases be held by participants for a period of 18 months from the purchase date. A total of 500,000 shares of our common stock are authorized for purchase under the ESPP Plan. For the fiscal year ended December 31, 2014, we purchased approximately 22,000 shares of our common stock under the ESPP Plan which amounted to approximately $494. For the fiscal year ended December 31, 2013, we purchased approximately 24,700 shares of our common stock under the ESPP Plan which amounted to approximately $482. The ESPP Plan is non-compensatory and, as a result, no compensation expense is recorded in our consolidated statement of operations for the fiscal years ended December 31, 2014, 2013 and 2012.
	Equity Incentive Plans
	In 2008, the Board approved and the Company’s stockholders adopted the MedAssets Inc. Long-Term Performance Incentive Plan (the “2008 Plan”). The 2008 Plan provides for the grant of non-qualified stock options, incentive stock options, restricted stock awards, restricted stock unit awards, performance awards, stock appreciation rights and other stock-based awards. As of December 31, 2014, we had approximately 5,263,000 shares remaining under our 2008 Plan available for grant.
	Equity awards issued under the 2008 Plan generally vest over five years of continuous service and have seven-year contractual terms. Service-based share awards generally vest over one to five years. Performance-based awards vest upon the attainment of one or more performance objectives over a specified period. We have outstanding stock option awards that were issued under previous plans that generally vest over three to five years of continuous service and have ten-year contractual terms.
	2014 Equity Award Grants
	In February 2014, the Compensation Committee of our Board of Directors (the “Compensation Committee”) approved an equity grant for certain eligible employees consisting of service-based and performance-based restricted stock units (“RSUs”). The purpose of the equity grant is to assist the Company in attracting, retaining, motivating, and rewarding certain individuals of the Company. The equity grant is intended to promote the creation of long-term value for stockholders of the Company by closely aligning the interests of such individuals with those of the stockholders. The total approved equity grant amounted to 1,218,826 RSUs with a grant date fair value of $25.06 per award and was comprised of: (i) 63,355 service-based RSUs that vest ratably each month through December 31, 2014; (ii) 469,011 service-based RSUs that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015; (iii) 343,230 performance-based RSUs using a net revenue performance metric that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015 provided the performance metric is achieved; and (iv) 343,230 performance-based RSUs using an adjusted EBITDA performance metric that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015 provided the performance metric is achieved.
	In May 2014, the Compensation Committee approved an equity grant for certain eligible employees consisting of service-based and performance-based RSUs. The total approved equity grant amounted to 8,982 RSUs with a grant date fair value of $23.54 per award and was comprised of: (i) 6,179 service-based RSUs that vest ratably each month through December 31, 2014; (ii) 2,107 service-based RSUs that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015; (iii) 348 performance-based RSUs using a net revenue performance metric that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015 provided the performance metric is achieved; and (iv) 348 performance-based RSUs using an adjusted EBITDA performance metric that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015 provided the performance metric is achieved.
	The measurement period for the net revenue performance-based awards is from January 1, 2014 through December 31, 2014. The net revenue performance metric is based on the achievement of an established net revenue target. The Company must achieve a minimum threshold of net revenue before any performance-based RSUs begin vesting. The equity award holders have an opportunity to earn between 50% and 100% of the performance-based equity awards once the minimum threshold has been met. If the minimum threshold is not met, the equity award holders will forfeit those awards.
	The measurement period for the adjusted EBITDA performance-based awards is from January 1, 2014 through December 31, 2014. The adjusted EBITDA performance metric is based on the achievement of an established adjusted EBITDA target. The Company must achieve a minimum threshold of adjusted EBITDA before any performance-based RSUs begin vesting. The equity award holders have an opportunity to earn between 50% and 100% of the performance-based equity awards once the minimum threshold has been met. If the minimum threshold is not met, the equity award holders will forfeit those awards.
	In May 2014, the Compensation Committee also approved an equity grant consisting of 100,000 performance-based RSUs using a net revenue performance metric that is a cliff-vesting award and is based on the achievement of a target cumulative annual growth rate over a three-year performance period. Depending on the cumulative revenue growth rate achieved, up to 200,000 RSUs can be earned. The RSUs have a grant date fair value of $23.54 per award and the measurement period is from January 1, 2014 through December 31, 2016. A certain minimum cumulative revenue growth rate must be achieved before any RSUs will vest on March 1, 2017. If the minimum threshold is not met, the equity award holder will forfeit the awards.
	In August 2014, the Compensation Committee approved an equity grant for certain eligible employees consisting of service-based RSUs. The total approved equity grant amounted to 6,328 RSUs with a grant date fair value of $21.97 per award that will primarily vest annually over three years of continuous service with the first annual vest date beginning on September 1, 2015.
	In September 2014, and in connection with the Sg2 Acquisition, the Compensation Committee approved an equity grant for certain eligible employees consisting of service-based and performance-based RSUs. The total approved equity grant amounted to 100,786 RSUs with a grant date fair value of $21.26 per award and was comprised of: (i) 30,095 service-based RSUs that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2016; and (ii) 70,691 performance-based RSUs using a Sg2 revenue performance metric based on the achievement of a target revenue amount over a three-year performance period. Depending on the Sg2 revenue achieved, up to 200,000 RSUs can be earned. A certain minimum Sg2 revenue amount must be achieved before any RSUs will vest beginning on March 1, 2015. If the minimum threshold is not met, the equity award holder will forfeit the awards.
	In November 2014, the Compensation Committee approved an equity grant for certain eligible employees consisting of service-based RSUs. The total approved equity grant amounted to 15,910 RSUs with a grant date fair value of $20.72 per award that will primarily vest annually over three years of continuous service with the first annual vest date beginning on December 1, 2015.
	Under all plans, our policy is to grant equity awards with an exercise price (or base price in the case of SSARs) equal to the fair market price of our stock on the date of grant.
	Equity Award Valuation
	Under generally accepted accounting principles for stock compensation for SSARs and stock options, we calculate the grant-date estimated fair value of share-based awards using a Black-Scholes valuation model. Determining the estimated fair value of share-based awards is judgmental in nature and involves the use of significant estimates and assumptions, including the expected term of the share-based awards, risk-free interest rates over the vesting period, expected dividend rates, the price volatility of the Company’s shares and forfeiture rates of the awards. The guidance requires forfeitures to be estimated at the time of grant and adjusted, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The forfeiture rate is estimated based on historical and expected experience. We base fair value estimates on assumptions we believe to be reasonable but that are inherently uncertain. Actual future results may differ materially from those estimates.

	The fair value of each equity award has been estimated as of the date of grant using the Black-Scholes option-pricing model with the following assumptions for the fiscal years ended December 31, 2014, 2013 and 2012:


			December 31,
			2014		2013		2012
	Range of calculated volatility		n/a		49.00%		49.3% - 51.6%
	Dividend yield		n/a		0%		0%
	Range of risk free interest rate		n/a		0.72%		0.62% - 0.92%
	Range of expected term		n/a		5.0 years		4.0 - 5.0 years
	Historically, it has not been practicable for us to estimate the expected volatility of our share price required by existing accounting requirements based solely on our own historical stock price volatility (i.e., trading history), given our limited history as a publicly traded company. Beginning in 2013, we had sufficient history as a public company and will estimate the expected volatility of our share price, which may impact our future share-based compensation. In accordance with generally accepted accounting principles for stock compensation, for certain grants awarded prior to January 1, 2013, we estimated the grant-date fair value of our shares using a combination of our own trading history and a volatility calculated (“calculated volatility”) from an appropriate industry sector index of comparable entities and using the “simplified method” as prescribed in Staff Accounting Bulletin No. 110, Share-based Payment, to calculate expected term. Dividend payments were not assumed, as we did not anticipate paying a dividend at the dates in which the various option grants occurred during the year. The risk-free rate of return reflects the interest rate offered for zero coupon treasury bonds over the expected term of the options. The expected term of the awards represents the period of time that options granted are expected to be outstanding.
	Equity Award Expense Attribution
	In general, for equity awards with graded-vesting, compensation cost is recognized using an accelerated method over the vesting or service period and is net of estimated forfeitures. In general, for equity awards with cliff-vesting, compensation cost is recognized using a straight-line method over the vesting or service period and is net of estimated forfeitures. For performance-based equity awards, compensation cost is adjusted each reporting period in which a change in performance achievement is determined and is net of estimated forfeitures. We evaluate the probability of performance achievement each reporting period and, if necessary, adjust share-based compensation expense based on expected performance achievement.
	Restricted Stock Units and Restricted Common Stock Awards
	We have issued restricted stock units and restricted common stock awards to employees, our Board and our senior advisory board. During 2014, 2013 and 2012, we issued approximately 1,451,000 units, 1,211,000 shares and 438,000 shares, respectively. During 2014, 2013 and 2012, the weighted-average grant date fair value of each restricted stock unit and restricted common stock share was $24.62, $18.44 and $14.00, respectively. The fair value of shares vested during the fiscal years ended December 31, 2014, 2013 and 2012 was $11,118, $5,732 and $10,584, respectively.

	A summary of changes in restricted units and shares during the fiscal year ended December 31, 2014 is as follows:


			Restricted Stock Units													Restricted Stock
			Total Units				Weighted			Weighted			Aggregate			Total			Weighted		Weighted		Aggregate
							Average			Average			Intrinsic			Shares(1,2)			Average		Average		Intrinsic
							Grant Date			Remaining			Value						Grant Date		Remaining		Value
							Fair Value			Contractual									Fair Value		Contractual
										Term											Term
	Non-vested restricted units and shares outstanding as of January 1, 2014			—				—						—			1,137,000		$	17.47		2 years
	Granted			1,451,000				24.62									—			—
	Vested			(63,000	)			24.89									(412,000	)		17.25
	Forfeited			(340,000	)			25.06									(96,000	)		17.08

	Restricted Units and Shares outstanding as of December 31, 2014			1,048,000			$	24.46			2 years		$	20,712			629,000		$	17.68		1 year	$	12,399


-1	Service-based shares are inclusive of certain restricted stock awards issued pursuant to the MedAssets, Inc. 2010 Special Stock Incentive Plan (the “Plan”). The Plan was adopted by the Company’s Board of Directors on November 23, 2010 in connection with the Broadlane Acquisition pursuant to an exception to the requirement for stockholder approval under NASDAQ rules.
-2	During the year, approximately 135,000 restricted shares were surrendered from equity award holders to settle their associated tax liability. The tax liability was paid by the Company on their behalf and amounted to approximately $3,197.
As of December 31, 2014, there was $17,905 of total unrecognized compensation cost related to unvested restricted common stock awards and restricted stock units that will be recognized over a weighted average period of 1.5 years.
SSARs
We have issued SSARs to employees, our Board and our senior advisory board. During 2013 and 2012, we issued approximately 3,000 and 653,000 SSARs, respectively. During 2013 and 2012 the weighted-average grant date fair value of each SSAR was $7.15 and $6.07, respectively. The fair value of SSARs vested during the fiscal years ended December 31, 2014, 2013 and 2012 was $1,842, $3,529 and $4,291, respectively.
A summary of changes in SSARs during the fiscal year ended December 31, 2014 is as follows:


		Total				Weighted			Weighted			Weighted			Aggregate
		SSARs(1)				Average			Average			Average			Intrinsic
						Grant Date			Base Price			Remaining			Value
						Fair Value						Contractual
												Term
SSARs outstanding as of January 1, 2014			1,750,000			$	6.41		$	16.52			4 years
Granted			—				—			—
Exercised			(388,000	)			6.2			16.35
Forfeited			(105,000	)			6.66			17.12

SSARs outstanding as of December 31, 2014			1,257,000			$	6.45		$	16.59			4 years		$	4,598

SSARs exercisable as of December 31, 2014			808,000			$	6.54		$	17.53			4 years		$	2,352


-1	During the year, equity award holders surrendered SSARs to settle their associated tax liability. The tax liability was paid by the Company on their behalf and amounted to approximately $219.

During the fiscal year ended December 31, 2014, we issued approximately 106,000 shares of common stock in connection with exercises of 388,000 SSARs.
During the fiscal year ended December 31, 2013, we issued approximately 267,000 shares of common stock in connection with exercises of 1,340,000 SSARs.
During the fiscal year ended December 31, 2012, we issued approximately 19,000 shares of common stock in connection with exercises of 173,000 SSARs.
As of December 31, 2014, there was $877 of total unrecognized compensation cost related to unvested SSARs that will be recognized over a weighted average period of 1.3 years.
Common Stock Option Awards
During the fiscal years ended December 31, 2014, 2013 and 2012, no service-based stock options were issued. The exercise price of all stock options described below was equal to the market price of our common stock on the date of grant (or “common stock grant-date fair value”), and therefore the intrinsic value of each option grant was zero.
A summary of changes in outstanding options during the fiscal year ended December 31, 2014 is as follows:


		Shares				Weighted			Weighted			Aggregate
						Average			Average			Intrinsic
						Exercise			Remaining			Value
						Price			Contractual
									Term
Options outstanding as of January 1, 2014			926,000			$	11.89			4 years
Granted			—				—
Exercised			(306,000	)			12.5
Forfeited			(133,000	)			4.87

Options outstanding as of December 31, 2014			487,000			$	13.42			3 years		$	3,242

Options exercisable as of December 31, 2014			485,000			$	13.4			3 years		$	3,242

The total fair value of stock options vested during the fiscal years ended December 31, 2014, 2013 and 2012 was $201, $737 and $2,246, respectively.
During the fiscal years ended December 31, 2014, 2013 and 2012, we issued approximately 306,000, 1,364,000 and 1,336,000 shares of common stock, respectively, in connection with employee stock option exercises for aggregate exercise proceeds of $3,829, $14,808 and $10,618, respectively.
The total intrinsic value of stock options exercised during the fiscal years ended December 31, 2014, 2013 and 2012 was $3,370, $14,180 and $10,606, respectively. Our policy for issuing shares upon stock option exercise is to issue new shares of common stock.
As of December 31, 2014, there was $2 of total unrecognized compensation cost related to outstanding stock option awards that will be recognized over a weighted average period of 1 year.

The following table summarizes the exercise price range, weighted average exercise price, and remaining contractual lives for the number of stock options outstanding as of December 31, 2014, 2013 and 2012:


		December 31,				December 31,			December 31,
		2014				2013			2012
Range of exercise prices		$	2.86 - $23.11			$	1.56 - $22.45		$	1.56 - $23.11
Number of options outstanding			487,000				926,000			2,342,000
Weighted average exercise price		$	13.42			$	11.89		$	11.31
Weighted average remaining contractual life			3.0 years				3.7 years			4.4 years

Income_Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Taxes	10. INCOME TAXES
	The provision for income tax expense (benefit) is as follows for the years ended December 31:


			2014				2013			2012
	Current expense
	Federal		$	24,812			$	12,580		$	574
	State			2,355				2,089			1,158

	Total current expense			27,167				14,669			1,732
	Deferred benefit
	Federal			(6,654	)			1,791			(3,110	)
	State			1,090				222			(102	)

	Total deferred (benefit) expense			(5,564	)			2,013			(3,212	)

	Provision for income taxes		$	21,603			$	16,682		$	(1,480	)

	A reconciliation between reported income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 35 percent is as follows at December 31, 2014, 2013 and 2012:


			2014				2013			2012
	Computed tax expense (benefit)		$	425			$	15,443		$	(2,925	)
	State taxes (net of federal benefit)			2,240				1,534			719
	Goodwill Impairment			18,388				—			—
	Meals & entertainment related to operations			683				(362	)		895
	Domestic production deduction			—				—			290
	Other permanent items			245				139			143
	Research & development credits			(1,050	)			(1,262	)		(196	)
	Uncertain tax positions			(214	)			31			(391	)
	Non deductible compensation			615				1,184			—
	Other			271				(25	)		(15	)

	Provision for income taxes		$	21,603			$	16,682		$	(1,480	)


	Deferred income taxes reflect the net effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities are as follows at December 31:


			2014				2013
	Deferred tax asset, current
	Accrued expenses		$	3,508			$	4,478
	Accounts receivable			991				967
	Deferred revenue			5,977				7,185
	Net operating loss carryforwards			148				174
	Returns and allowances			960				1,006
	AMT credit			—				3,520

	Deferred tax asset, current			11,584				17,330
	Valuation allowance			(226	)			(1,539	)

	Total deferred tax asset, current			11,358				15,791

	Deferred tax liability, current
	Prepaid expenses			(5,576	)			(11,256	)

	Total deferred tax liability, current			(5,576	)			(11,256	)

	Net deferred tax asset, current		$	5,782			$	4,535



			2014				2013
	Deferred tax asset, non-current
Capital lease		$	954			$	947
Capital loss limitation			—				1,016
Debt issuance costs			628				529
Deferred compensation			10,272				8,652
Deferred revenue			2,469				2,395
Net operating loss carryforwards			4,688				4,813
Other			326				371

Deferred tax asset, non-current			19,337				18,723
Valuation allowance			(3,684	)			(3,412	)

Total deferred tax asset, non-current			15,653				15,311

Deferred tax liability, non-current
Capitalized software costs			(43,832	)			(39,786	)
Prepaid expenses			(4,961	)			—
Fixed assets			(4,347	)			(4,929	)
Intangible assets			(79,120	)			(91,679	)

Total deferred tax liability, non-current			(132,260	)			(136,394	)

Net deferred liability, non-current		$	(116,607	)		$	(121,083	)

We have historically maintained a valuation allowance on certain deferred tax assets, such as capital losses and various state net operating losses. In assessing the ongoing need for a valuation allowance, we consider recent operating results, the expected scheduled reversal of deferred tax liabilities, projected future taxable benefits and tax planning strategies. As a result of this assessment, we recorded a $1,016 decrease to our valuation allowance for the expiration of our capital loss carryforward and a $25 decrease to our valuation allowance on our state net operating losses for the year ended December 31, 2014.
As of December 31, 2014, we have state net operating losses of $107,854 (expiring 2020 – 2034). As of December 31, 2014 we have federal credits of $55 (expiring 2019-2024).
Cash paid for income taxes amounted to $27,438 and $7,660 for the years ended December 31, 2014 and 2013, respectively.
We reversed net interest expense and penalties of $153 related to changes in estimates concerning settlement of certain state income tax examination and recorded net interest expense and penalties of $47 for the fiscal years ended December 31, 2014 and December 31, 2013, respectively. As of December 31, 2014, the total amount of interest and penalties included on our consolidated balance sheet was $279.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:


Balance at December 31, 2011		$	1,299
Additions for tax positions of prior years			50
Settlements and lapse of statue of limitations			(679	)

Balance at December 31, 2012		$	670

Additions based on tax positions related to the current year			223
Reductions for tax positions of prior years			(17	)

Balance at December 31, 2013		$	876

Additions for tax positions of prior years			333
Decreases for tax positions of prior years			(180	)
Settlements and lapse of statue of limitations			(459	)

Balance at December 31, 2014		$	570

Included in our unrecognized tax benefits are $579 of uncertain positions that would impact our effective rate if recognized. We anticipate releasing $520 of unrecognized tax benefits in 2015.
Our consolidated U.S. federal income tax returns for tax years 1999 to 2013 remain subject to examination by the Internal Revenue Service (or “IRS”) for net operating loss carryforward and credit carryforward purposes. For years 1999 to 2010, the statute for assessments and refunds has generally expired; however, tax attributes for those years may still be examined, which would impact the tax years 2011 and forward.

Earnings_Loss_Per_Share

Earnings (Loss) Per Share	12 Months Ended
Earnings (Loss) Per Share	Dec. 31, 2014
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	11. EARNINGS (LOSS) PER SHARE
	We calculate earnings per share (or “EPS”) in accordance with the GAAP relating to earnings per share. Basic EPS is calculated by dividing reported net loss by the weighted-average number of common shares outstanding for the reported period following the two-class method. Diluted EPS reflects the potential dilution that could occur if our stock options, stock settled stock appreciation rights, unvested restricted stock, stock warrants and shares that were purchasable pursuant to our employee stock purchase plan were exercised and converted into our common shares during the reporting periods.

	The following table is a reconciliation of the denominator for basic and diluted loss per share for the years ended December 31, 2014, 2013 and 2012.


		Year Ended December 31,
		2014			2013		2012
	Numerator for Basic and Diluted (Loss) Income Per Share:
	Net (loss) income		(20,390	)		27,441		(6,878	)
	Denominator for basic (loss) income per share weighted average shares		59,811,000			59,705,000		57,452,000
	Effect of dilutive securities:
	Stock options		—			590,000		—
	Stock-settled stock appreciation rights		—			267,000		—
	Restricted stock and stock warrants		—			616,000		—

	Denominator for diluted (loss) income per share — adjusted weighted average shares and assumed conversions		59,811,000			61,178,000		57,452,000
	Basic (loss) income per share:
	Basic net (loss) income from continuing operations	$	(0.34	)	$	0.46	$	(0.12	)

	Diluted net (loss) income per share:
	Diluted net (loss) income from continuing operations	$	(0.34	)	$	0.45	$	(0.12	)

	During the fiscal years ended December 31, 2014 and 2012, basic and diluted EPS are the same because potentially dilutive securities have been excluded from the calculation of diluted EPS given our net loss for each year. In addition, the effect of certain dilutive securities have been excluded because the impact is anti-dilutive as a result of certain securities being “out of the money” with strike prices greater than the average market price during the period presented. The following table provides a summary of those potentially dilutive securities that have been excluded from the above calculation of diluted EPS:


		Year Ended December 31,
		2014			2013		2012
	Stock options		258,000			—		878,000
	Stock-settled stock appreciation rights		263,000			—		38,000
	Restricted stock and stock warrants		775,000			—		234,000

	Total		1,296,000			—		1,150,000

Segment_Information

Segment Information	12 Months Ended
Segment Information	Dec. 31, 2014
Segment Reporting [Abstract]
Segment Information	12. SEGMENT INFORMATION

	We deliver our solutions and manage our business through two reportable business segments, Spend and Clinical Resource Management (or “SCM”) and Revenue Cycle Management (or “RCM”).


		•		Spend and Clinical Resource Management. Our SCM segment provides a comprehensive suite of technology-enabled services that help our clients manage their expense categories. Our solutions lower supply and medical device pricing and utilization by managing the procurement process through our group purchasing organization (“GPO”) portfolio of contracts, consulting services and business intelligence tools.


		•		Revenue Cycle Management. Our RCM segment provides a comprehensive suite of products and services spanning the hospital revenue cycle workflow—from patient access and financial responsibility, charge capture and integrity, pricing analysis, claims processing and denials management, payor contract management, revenue recovery and accounts receivable services. Our workflow solutions, together with our data management, compliance and audit tools, increase revenue capture and cash collections, reduce accounts receivable balances and increase regulatory compliance.

	GAAP relating to segment reporting, defines reportable segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing financial performance. The guidance indicates that financial information about segments should be reported on the same basis as that which is used by the chief operating decision maker in the analysis of performance and allocation of resources. Management of the Company, including our chief operating decision maker, uses what we refer to as Segment Adjusted EBITDA as its primary measure of profit or loss to assess segment performance and to determine the allocation of resources. We define Segment Adjusted EBITDA as segment net income (loss) before net interest expense, income tax expense (benefit), depreciation and amortization (“EBITDA”) as adjusted for other non-recurring, non-cash or non-operating items. Our chief operating decision maker uses Segment Adjusted EBITDA to facilitate a comparison of our operating performance on a consistent basis from period to period. Segment Adjusted EBITDA includes expenses associated with sales and marketing, general and administrative and product development activities specific to the operation of the segment. General and administrative corporate expenses that are not specific to the segments are not included in the calculation of Segment Adjusted EBITDA. These expenses include the costs to manage our corporate offices, interest expense on our credit facilities and expenses related to being a publicly-held company. All reportable segment revenues are presented net of inter-segment eliminations and represent revenues from external clients.

	The following tables present Segment Adjusted EBITDA and financial position information as utilized by our chief operating decision maker. A reconciliation of Segment Adjusted EBITDA to consolidated net income is included. General corporate expenses are included in the “Corporate” line item. “RCM” represents the Revenue Cycle Management segment and “SCM” represents the Spend and Clinical Resource Management segment. Other assets and liabilities are included to provide a reconciliation to total assets and total liabilities.

	The following tables represent our results of operations, by segment, for the fiscal years ended December 31, 2014, 2013 and 2012:



			Years Ended December 31,
			2014				2013				2012
	Revenue:
	SCM
	Gross administrative fees(1)		$	494,927			$	472,113			$	427,698
	Revenue share obligation(1)			(203,564	)			(182,638	)			(160,783	)

	Net administrative fees			291,363				289,475				266,915
	Other service fees(2)			154,242				134,987				126,656

	Total SCM net revenue			445,605				424,462				393,571
	RCM
	Revenue cycle technology			188,958				180,362				169,878
	Revenue cycle services			85,666				75,592				76,672

	Total RCM net revenue			274,624				255,954				246,550

	Total net revenue			720,229				680,416				640,121
	Operating expenses:
	SCM			327,903				317,977				295,486
	RCM			291,575				223,030				214,935
	Corporate			54,290				48,666				44,502

	Total operating expenses			673,768				589,673				554,923

	Operating income (loss):
	SCM			117,702				106,485				98,085
	RCM			(16,951	)			32,924				31,615
	Corporate			(54,290	)			(48,666	)			(44,502	)

	Total operating income			46,461				90,743				85,198

	Interest expense			(45,563	)			(46,907	)			(66,045	)
	Loss on debt extinguishment			—				—				(28,196	)
	Other income			315				287				685

	Income (loss) before income taxes			1,213				44,123				(8,358	)
	Income tax expense (benefit)			21,603				16,682				(1,480	)

	Net (loss) income		$	(20,390	)		$	27,441			$	(6,878	)

	Segment Adjusted EBITDA
	SCM		$	195,003			$	189,393			$	176,893
	RCM			67,440				62,551				59,451

	Total Segment Adjusted EBITDA		$	262,443			$	251,944			$	236,344
Corporate			(28,406	)			(31,103	)			(29,006	)

Total Adjusted EBITDA(1)		$	234,037			$	220,841			$	207,338


-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.
-2	Other service fees primarily consists of consulting, services and technology fees.



		Years Ended December 31,
		2014				2013				2012
Capital expenditures(1):
SCM		$	25,345			$	16,181			$	19,141
RCM			32,805				38,345				35,180
Corporate			5,108				4,292				12,105

Total		$	63,258			$	58,818			$	66,426


-1	Capital expenditures consist of purchases of property and equipment and capitalized software development costs (internal and external use).



		December 31,
		2014				2013
Financial Position:
Accounts receivable, net
SCM		$	74,337			$	38,319
RCM			53,129				49,314
Corporate			275				3

Total accounts receivable, net			127,741				87,636
Other assets
SCM			1,067,039				955,252
RCM			439,333				503,359
Corporate			84,683				67,502

Total other assets			1,591,055				1,526,113

Total assets		$	1,718,796			$	1,613,749

SCM accrued revenue share obligation		$	91,864			$	77,398
Deferred revenue
SCM			51,958				22,775
RCM			39,494				40,117

Total deferred revenue			91,452				62,892
Notes payable			556,000				439,500
Bonds payable			325,000				325,000
Other liabilities
SCM			36,938				36,393
RCM			23,952				26,113
Corporate			147,103				156,664

Total other liabilities			207,993				219,170

Total liabilities		$	1,272,309			$	1,123,960



GAAP relating to segment reporting requires that the total of the reportable segments’ measures of profit or loss be reconciled to the Company’s consolidated operating results. The following table reconciles Segment Adjusted EBITDA to consolidated net (loss) income for each of the fiscal years ended December 31, 2014, 2013 and 2012:



		Year Ended December 31,
		2014				2013				2012
SCM Adjusted EBITDA		$	195,003			$	189,393			$	176,893
RCM Adjusted EBITDA			67,440				62,551				59,451

Total Segment Adjusted EBITDA			262,443				251,944				236,344
Depreciation			(34,843	)			(29,948	)			(19,991	)
Depreciation (included in cost of revenue)			(3,131	)			(2,157	)			(1,859	)
Amortization of intangibles			(57,593	)			(62,723	)			(72,652	)
Amortization of intangibles (included in cost of revenue)			—				—				(557	)
Interest expense, net of interest income(1)			—				—				4
Income tax expense			(62,568	)			(52,600	)			(22,988	)
Impairment of goodwill(2)			(52,539	)			—				—
Share-based compensation expense(3)			(9,162	)			(7,922	)			(5,097	)
Purchase accounting adjustments(4)			(979	)			—				—
Restructuring, acquisition and integration-related expenses(5)			(3,466	)			(10,070	)			(6,348	)

Total reportable segment net income			38,162				86,524				106,856
Corporate net (loss) income			(58,552	)			(59,083	)			(113,734	)

Consolidated net (loss) income		$	(20,390	)		$	27,441			$	(6,878	)


-1	Interest income is included in other income (expense) and is not netted against interest expense in our consolidated statements of operations.
-2	The impairment during the fiscal year ended December 31, 2014 consisted of the write-off of goodwill relating to our revenue cycle services operating unit.
-3	Represents non-cash share-based compensation to both employees and directors. We believe excluding this non-cash expense allows us to compare our operating performance without regard to the impact of share-based compensation, which varies from period to period based on amount and timing of grants.
-4	Represents the effect on revenue of adjusting the acquired deferred revenue balance associated with the Sg2 Acquisition to fair value at the acquisition date.
-5	Represents the amount attributable to restructuring, acquisition and integration-related costs which include costs such as severance, retention, salaries relating to redundant positions, certain performance-related salary-based compensation, operating infrastructure costs and facility consolidation costs.

Derivative_Financial_Instrumen

Derivative Financial Instruments	12 Months Ended
Derivative Financial Instruments	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	13. DERIVATIVE FINANCIAL INSTRUMENTS
	On December 13, 2012, we terminated our two floating-to-fixed rate LIBOR-based forward starting interest rate swaps, originally entered into on May 5, 2011. The swaps were originally scheduled to fully terminate by February 2015. Such early termination was deemed to be a termination of all future obligations between us and each counterparty. In consideration of the early termination, we paid a total of $8,209 to the counterparties on December 17, 2012. Prior to the termination, the fair values of the swaps were recorded in other long-term liabilities and accumulated other comprehensive loss on our balance sheet. The termination of the swaps resulted in the payment of such liability and the reclassification of the related accumulated other comprehensive loss to current period expense. The result was a charge to expense for the fiscal year ended December 31, 2012 of $8,209 ($5,227 net of tax). We have no assets or liabilities remaining on our Consolidated Balance Sheet with respect to these interest rate swaps as of December 31, 2013.
	The effects of derivative instruments designated as cash flow hedges on income and AOCI are summarized below:


		Fiscal Year Ended December 31,
	Derivatives designated as cash flow hedges	2014		2013		2012
	Total unrealized loss recognized in other comprehensive income — interest rate contracts	$	—	$	—	$	(1,166)
	Total realized loss reclassified into earnings — interest rate contracts	$	—	$	—	$	5,227

Fair_Value_Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Measurements	14. FAIR VALUE MEASUREMENTS
	We measure fair value for financial instruments, such as derivatives and non-financial assets, when a valuation is necessary, such as for impairment of long-lived and indefinite-lived assets when indicators of impairment exist in accordance with GAAP for fair value measurements and disclosures. This defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measures required under other accounting pronouncements, but does not change existing guidance as to whether or not an instrument is carried at fair value.
	Refer to Note 13 for information and fair values of our derivative instruments measured on a recurring basis under GAAP for fair value measurements and disclosures.
	In estimating our fair value disclosures for financial instruments, we use the following methods and assumptions:

		•	Cash and cash equivalents. The carrying value reported in the consolidated balance sheets for these items approximates fair value due to the high credit standing of the financial institutions holding these items and their liquid nature;

		•	Accounts receivable, net. The carrying value reported in the consolidated balance sheets is net of allowances for doubtful accounts which includes a degree of counterparty non-performance risk;

		•	Accounts payable and current liabilities. The carrying value reported in the consolidated balance sheets for these items approximates fair value, which is the likely amount for which the liability with short settlement periods would be transferred to a market participant with a similar credit standing as the Company;

		•	Notes payable. The carrying value of our long-term notes payable reported in the consolidated balance sheets approximates fair value since they bear interest at variable rates. Refer to Note 6 for further information; and

		•	Bonds payable. The carrying value of our long-term bonds payable reported in the consolidated balance sheets approximates fair value. Refer to Note 6 for further information.

Valuation_and_Qualifying_Accou

Valuation and Qualifying Accounts	12 Months Ended
Valuation and Qualifying Accounts	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
Valuation and Qualifying Accounts	15. VALUATION AND QUALIFYING ACCOUNTS
	We maintain an allowance for doubtful accounts that is recorded as a contra asset to our accounts receivable balance; a sales return reserve and client allowance that is recorded as a contra revenue account; and, a self-insurance accrual related to the medical and dental insurance provided to our employees. The following table sets forth the change in each of those reserves for the years ended December 31, 2014, 2013, and 2012.
	Valuation and Qualifying Accounts


			Balance at		Charged to Bad		Write offs Net of			Balance at End
			Beginning of		Debt(1)		Recoveries(2)			of Year
			Year
	Allowance for Doubtful Accounts
	Year ended December 31, 2014		$	2,568	$	195	$	(122	)	$	2,641
	Year ended December 31, 2013			3,046		—		(478	)		2,568
	Year ended December 31, 2012			3,891		735		(1,580	)		3,046

	-1	Additions to the allowance account through the normal course of business are charged to expense.
	-2	Write-offs reduce the balance of accounts receivable and the related allowance for doubtful accounts indicating management’s belief that specific balances are not recoverable.


			Balance at		Charged to Net		Write offs(2)			Balance at End
			Beginning of		Revenue(1)					of Year
			Year
	Client Allowance and Return Reserve
	Year ended December 31, 2014		$	2,673	$	1,125	$	(1,243	)	$	2,555
	Year ended December 31, 2013			2,759		1,675		(1,761	)		2,673
	Year ended December 31, 2012			2,129		2,126		(1,496	)		2,759

	-1	Includes client service allowance and sales returns. Additions to the allowance through the normal course of business reduce net revenue.
	-2	Write-offs reduce the balance of the client allowance and return reserve.


			Balance at		Charged to		Claims Payments(3)			Balance at End of
			Beginning of		expense(2)					Year
			Year
	Self Insurance Accrual(1)
	Year ended December 31, 2014		$	2,821	$	25,943	$	(26,420	)	$	2,344
	Year ended December 31, 2013			2,621		25,161		(24,961	)		2,821
	Year ended December 31, 2012			2,966		25,505		(25,850	)		2,621

	-1	We have a self-insurance policy to cover our employees’ medical and dental insurance.
	-2	Estimates of insurance claims expected to be incurred through the normal course of business are charged to expense.
	-3	Actual insurance claims payments reduce the self-insurance accrual.

Quarterly_Financial_Informatio

Quarterly Financial Information	12 Months Ended
Quarterly Financial Information	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information	16. QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
	Unaudited summarized financial data by quarter for the years ended December 31, 2014 and 2013 is as follows:


		First		Second		Third		Fourth
		Quarter		Quarter		Quarter		Quarter
	Fiscal 2014
	Net revenue	$	170,867	$	175,415	$	175,705	$	198,242
	Gross profit		133,436		135,054		133,266		146,621
	Net income (loss)		7,678		6,596		7,740		(42,404	)
	Net income (loss) per basic share	$	0.13	$	0.11	$	0.13	$	(0.71	)

	Net income (loss) per diluted share	$	0.12	$	0.11	$	0.13	$	(0.71	)


		First		Second		Third		Fourth
		Quarter		Quarter		Quarter		Quarter
	Fiscal 2013
	Net revenue	$	172,837	$	170,742	$	166,371	$	170,466
	Gross profit		138,569		133,246		128,125		128,526
	Net income		7,704		5,084		6,902		7,751
	Net income per basic share	$	0.13	$	0.09	$	0.12	$	0.13

	Net income per diluted share	$	0.13	$	0.08	$	0.11	$	0.13

Related_Party_Transaction

Related Party Transaction	12 Months Ended
Related Party Transaction	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transaction	17. RELATED PARTY TRANSACTION
Related Party Transaction	We had an agreement with John Bardis, formerly our chief executive officer, for the use of an airplane owned by JJB Aviation, LLC, a limited liability company, owned by Mr. Bardis. We paid Mr. Bardis at market-based rates for the use of the airplane for business purposes. The audit committee of the board of directors reviews such usage of the airplane annually. During the fiscal years ended December 31, 2014, 2013 and 2012, we incurred charges of $1,621, $2,250 and $1,861, respectively, related to transactions with Mr. Bardis. On February 17, 2015, the Company entered into a Transition and Consulting Agreement (the “Transition Agreement”) with Mr. Bardis in connection with Mr. Bardis’s resignation from his positions with the Company. Pursuant to the Transition Agreement, the Company’s agreement to use the airplane owned by JJB Aviation, LLC was terminated effective as of January 1, 2015.

Subsequent_Events

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	18. SUBSEQUENT EVENTS
	We have evaluated subsequent events for recognition or disclosure in the consolidated financial statements filed on Form 10-K with the SEC and no events have occurred that require disclosure, except for the following:
	In January 2015, our management approved and initiated a plan to restructure our operations which included certain management changes within our SCM and RCM segments. We expect to incur approximately $1,600 in restructuring costs.
	In February 2015, our Board of Directors authorized an extension to our existing share repurchase program until February 29, 2016 and increased the total dollar amount available for the repurchase of shares of our common stock to $100,000 subject to certain restrictions under our Credit Agreement and Indenture.

	On February 17, 2015, Mr. Bardis resigned as the chairman of the Company’s board of directors (the “Board”) and chief executive officer for personal reasons, effective immediately. In connection with Mr. Bardis’s resignation, the Company entered into the Transition Agreement with Mr. Bardis, pursuant to which Mr. Bardis will transition to a consulting role with the Company for a term of three years (the “Term”) to provide consulting, business development and similar services of a non-operating nature for an annual consulting fee of $650. Mr. Bardis will remain a member of the Board until the Company’s 2015 Annual Meeting of Stockholders, following which he will have the title of Non-Executive Chairman Emeritus during the Term. Following Mr. Bardis’s resignation, the Board appointed Mr. R. Halsey Wise as Chairman and chief executive officer of the Company, effective immediately. The Company filed an 8-K on February 17, 2015 disclosing the specific terms of the resignation, Transition Agreement and new appointment of its chairman and chief executive officer.

Description_of_Business_and_Si1

Description of Business and Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Basis of Presentation

Use of Estimates

Cash and Cash Equivalents

Additionally, we have a concentration of credit risk arising from cash deposits held in excess of federally insured amounts totaling $11,600 as of December 31, 2014.

Accounts Receivables and Allowance

Client Service Allowance

Financial Instruments

The fair value of the bonds payable is calculated based on quoted market prices for the same or similar issues or on rates currently offered to the Company for similar debt instruments.

Revenue Recognition

Administrative Fees

Year Ended December 31,

2014

2013

2012

Gross administration fees

494,927

472,113

427,698

Less: Revenue share obligation

(203,564

)

(182,638

)

(160,783

)

Administrative fees, net

291,363

289,475

266,915

Other Service Fees

Consulting Fees

Consulting Fees with Performance Targets

Subscription and Implementation Fees

Transaction Fees and Contingent Service Fees

Other

Other fees are primarily earned for our annual client and vendor meeting. Fees for our annual client and vendor meeting are recognized when the meeting is held and related obligations are performed.

Revenue Recognition — Multiple-Deliverable Revenue Arrangements

Our revenue recognition policy for multiple-deliverable revenue arrangements is as follows:

Deferred Costs

Property and Equipment

Useful Lives

(in years)

Buildings

Furniture and fixtures

Computers and equipment

7-May

Leasehold improvements

Term of lease

Purchased software and capitalized software development costs (internal use)

5-Mar

Product Development Costs

Goodwill and Intangible Assets - Indefinite Life

Goodwill and Intangible Assets — Indefinite Life

As of December 31, 2014 and 2013, intangible assets with indefinite lives consist of goodwill. See Note 3 for further details.

Intangible Assets - Definite Life

Intangible Assets — Definite Life

The intangible assets with definite lives are comprised of our customer base, developed technology, non-compete agreements and certain trade name assets. See Note 4 for further details.

We evaluate indefinite-lived intangibles for impairment when events or changes in circumstances indicate that the carrying value of such assets may not be recoverable.

Business Combinations

Restructuring, Acquisition and Integration - Related Expenses

Restructuring, Acquisition and Integration — Related Expenses

Deferred Revenue

For the years ended December 31, 2014 and 2013, deferred revenues recorded that are contingent upon meeting performance targets were $8,441 and $6,516, respectively.

The following table summarizes the deferred revenue categories and balances as of:

December 31,

2014

2013

Software and SaaS implementation fees

55,152

27,393

Service fees

19,241

22,363

Administrative fees

15,715

10,935

Other fees

1,344

2,201

Deferred revenue, total

91,452

62,892

Less: Deferred revenue, current portion

(76,034

)

(46,523

)

Deferred revenue, non-current portion

15,418

16,369

Revenue Share Obligation and Rebates

We accrue revenue share obligation and rebates for certain clients according to our: (i) revenue share program and (ii) vendor rebate program.

Advertising Costs

Advertising costs are expensed as incurred. Advertising expense for the years ended December 31, 2014, 2013 and 2012 was $2,598, $3,196 and $2,750, respectively.

Defined Contribution Plan

Share-Based Compensation

Derivative Financial Instruments

Income Taxes

Sales Taxes

Basic and Diluted Net Income and Loss Per Share

Comprehensive Income

Comprehensive income reflects the change in equity during the periods presented and is comprised of all components of net income and all components of other comprehensive income.

Recent Accounting Pronouncements

Going Concern

Share-Based Compensation

Revenue Recognition

Discontinued Operations

Income Taxes

Obligations Resulting from Joint and Several Liability Arrangements

Description_of_Business_and_Si2

Description of Business and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Net Administrative Fee Revenues	The following shows the details of net administrative fee revenues for the years ended December 31, 2014, 2013 and 2012:


		Year Ended December 31,
		2014			2013			2012
	Gross administration fees	$	494,927		$	472,113		$	427,698
	Less: Revenue share obligation		(203,564	)		(182,638	)		(160,783	)

	Administrative fees, net	$	291,363		$	289,475		$	266,915
Depreciation of Property and Equipment	Depreciation of property and equipment (which includes amortization of capitalized internal use software) is computed on the straight-line method over the estimated useful lives of the assets which are as follows:



		Useful Lives
		(in years)
	Buildings		30
	Furniture and fixtures		7
	Computers and equipment		7-May
	Leasehold improvements		Term of lease
	Purchased software and capitalized software development costs (internal use)		5-Mar
Summary of Deferred Revenue	The following table summarizes the deferred revenue categories and balances as of:


		December 31,
		2014			2013
	Software and SaaS implementation fees	$	55,152		$	27,393
	Service fees		19,241			22,363
	Administrative fees		15,715			10,935
	Other fees		1,344			2,201

	Deferred revenue, total		91,452			62,892
	Less: Deferred revenue, current portion		(76,034	)		(46,523	)

	Deferred revenue, non-current portion	$	15,418		$	16,369

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
Property and Equipment (Tables)	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and equipment consists of the following as of:



		December 31,
		2014			2013
	Land	$	1,200		$	1,200
	Buildings		8,821			8,821
	Furniture and fixtures		14,806			14,130
	Computers and equipment		65,006			58,710
	Leasehold improvements		21,904			20,700
	Purchased software		37,828			30,931
	Capitalized software development costs (internal use)		186,076			147,828

			335,641			282,320
	Accumulated depreciation and amortization		(165,323	)		(124,573	)

	Property and equipment, net	$	170,318		$	157,747

Goodwill_Tables

Goodwill (Tables)	12 Months Ended
Goodwill (Tables)	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Components of Goodwill	Goodwill consists of the following as of:


		December 31,
		2014			2013
	Goodwill, net	$	1,058,414		$	1,027,847
Changes in Goodwill	The changes in goodwill are summarized as follows, consolidated and by segment, for the years ended December 31, 2014 and 2013:


		December 31,
		Consolidated			SCM		RCM
	Balance, December 31, 2012 and 2013	$	1,027,847		$	645,202	$	382,645
	Sg2 acquisition (Note 5)		81,476			81,476		—
	TRG acquisition (Note 5)		1,630			1,630		—
	RCS impairment loss		(52,539	)		—		(52,539	)

	Balance, December 31, 2014	$	1,058,414		$	728,308	$	330,106

Other_Intangible_Assets_Tables

Other Intangible Assets (Tables)	12 Months Ended
Other Intangible Assets (Tables)	Dec. 31, 2014
Text Block [Abstract]
Intangible Assets with Definite Lives	Intangible assets with definite lives consist of the following:



			Weighted		Gross		Accumulated			Net
			Average		Carrying		Amortization
			Remaining		Amount
			Amortization
			Period
			(Years)(1)
	December 31, 2014
	Customer base			3 years	$	529,145	$	(287,187	)	$	241,958
	Developed technology			3 years		43,900		(12,375	)		31,525
	Trade name			2 years		1,100		(100	)		1,000
	Non-compete agreement			2 years		2,080		(156	)		1,924

				3 years	$	576,225	$	(299,818	)	$	276,407


	-1	The period represents the weighted average amortization period remaining in total and for each asset class.



			Weighted		Gross		Accumulated			Net
			Average		Carrying		Amortization
			Remaining		Amount
			Amortization
			Period
			(Years)(1)
	31-Dec-13
	Customer base			3 years	$	510,547	$	(248,094	)	$	262,453
	Developed technology			2 years		13,300		(8,313	)		4,987

				3 years	$	523,847	$	(256,407	)	$	267,440


	-1	The period represents the weighted average amortization period remaining in total and for each asset class.
Future Amortization Expense of Definite-Lived Intangible Assets	developed technology related to definite-lived intangible assets. Future amortization expense of definite-lived intangibles as of December 31, 2014, is as follows:


			Amount
	2015		$	58,831
	2016			51,897
	2017			47,715
	2018			41,894
	2019			37,310
	Thereafter			38,760

			$	276,407

Restructuring_Acquisition_and_1

Restructuring Acquisition and Integration-Related Expenses (Tables)	12 Months Ended
	Dec. 31, 2014
Text Block [Abstract]
Summary of Assets Acquired and Liabilities Assumed	The following table summarizes the consideration paid for Sg2 and the preliminary amounts of the assets acquired and liabilities assumed recognized at the acquisition date:



	Fair value of total consideration transferred	$	138,201

	Recognized amounts of identifiable assets acquired and liabilities assumed
	Current assets	$	11,090
	Property and equipment		2,559
	Intangible assets		65,700
	Current liabilities		(21,849	)
	Long-term liabilities		(775	)

	Total identifiable net assets		56,725
	Goodwill		81,476

		$	138,201

Summary of Preliminary Fair Value Estimates	Our preliminary fair value estimates are as follows:




		Preliminary			Weighted-
		Estimated			average
		fair value			useful lives
	Customer base	$	32,300			11 year life
	Developed technology		30,600			6 year life
	Tradename		1,100			3 year life
	Non-compete agreement		1,700			3 year life

	Total acquired identified intangibles	$	65,700
Proforma of Financial Information	The following pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the Sg2 Acquisition had taken place at the beginning of each period:


		Pro forma
		Year Ended December 31,
		2014			2013
	Net revenue	$	752,117		$	715,709
	Net (loss) income		(24,225	)		15,473
	Basic net (loss) income per share	$	(0.41	)	$	0.26
	Diluted net (loss) income per share	$	(0.41	)	$	0.25
	Basic weighted average shares		59,811			59,705
	Diluted weighted average shares		59,811			61,178

Notes_and_Bonds_Payable_Tables

Notes and Bonds Payable (Tables)	12 Months Ended
Notes and Bonds Payable (Tables)	Dec. 31, 2014
Debt Disclosure [Abstract]
Summary of Notes Payable	Our notes and bonds payable are summarized as follows as of:


			December 31,
			2014			2013
	Term A facility		$	225,000		$	237,500
	Term B facility			179,000			192,000
	Revolving credit facility			152,000			10,000

	Total notes payable			556,000			439,500
	Bonds payable			325,000			325,000

	Total notes and bonds payable			881,000			764,500
	Less: current portions			(29,583	)		(15,500	)

	Total long-term notes and bonds payable		$	851,417		$	749,000

Percentage of Redemption Prices	The Company has the option to redeem all or a part of the Notes, at the following redemption prices:


	Year		Percentage
	2014			104	%
	2015			102	%
	2016 and thereafter			100	%
Debt Maturities and Scheduled Principal Repayments	The following table summarizes our stated debt maturities and scheduled principal repayments as of December 31, 2014:


	Year		Term A Facility			Term B Facility(2)			Revolving		Senior		Total
									Credit Facility		Unsecured
											Notes
	2015(1)		$	23,112		$	6,471		$	—	$	—	$	29,583
	2016			25,000			3,000			—		—		28,000
	2017			176,888			3,000			152,000		—		331,888
	2018			—			3,000			—		325,000		328,000
	2019			—			163,529			—		—		163,529

			$	225,000		$	179,000		$	152,000	$	325,000	$	881,000


	-1	Includes mandatory 2014 excess flow payment of $7,833 payable during the first quarter of 2015.
	-2	The Term B Facility matures on December 13, 2019; however, the facility will mature in full on May 15, 2018 if our outstanding senior notes have not been repaid or refinanced in full by such date.
Future Payments of Finance Obligation	Future payments of the finance obligation as of December 31, 2014 are as follows:


			Obligations
			Under
			Capital
			Lease
	2015		$	1,114
	2016			1,114
	2017			8,600

				10,828
	Less: Amounts representing interest			(2,059	)

	Net present value of capital lease obligation			8,769
	Less: Amount representing current portion			(294	)

	Finance obligation, less current portion		$	8,475

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
Commitments and Contingencies (Tables)	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Future Minimum Rental Payments Under Operating Leases	Future minimum rental payments under operating leases with initial or remaining non-cancelable lease terms of one year or more as of December 31, 2014 are as follows:


		Operating
		Lease
	2015	$	13,342
	2016		8,651
	2017		8,956
	2018		9,962
	2019		8,855
	Thereafter		69,796

		$	119,562

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	12 Months Ended
Stockholders' Equity (Tables)	Dec. 31, 2014
Equity [Abstract]
Summary of Cost of Shares Purchased	The repurchased shares have not been retired and constitute authorized but unissued shares.

		December 31,
		2014		2013		2012
	Number of shares repurchased		1,784,645		—		62,334
	Cost of shares repurchased	$	42,771	$	—	$	600

ShareBased_Compensation_Tables

Share-Based Compensation (Tables)	12 Months Ended
Share-Based Compensation (Tables)	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of Total Share-Based Compensation Expense	Total share-based compensation expense (inclusive of restricted common stock, RSUs, common stock options, and SSARs) for the fiscal years ended December 31, 2014, 2013 and 2012 is reflected in our consolidated statements of operations as noted below:


			December 31,
			2014			2013		2012
	Cost of revenue		$	5,510		$	3,866	$	2,165
	Product development			954			635		181
	Selling and marketing			2,622			2,251		1,489
	General and administrative			8,763			7,744		6,456

	Total share-based compensation expense		$	17,849		$	14,496	$	10,291
Fair Value of Equity Awards as of Date of Grant Using Black-Scholes Option-Pricing Model Assumptions	The fair value of each equity award has been estimated as of the date of grant using the Black-Scholes option-pricing model with the following assumptions for the fiscal years ended December 31, 2014, 2013 and 2012:


			December 31,
			2014		2013	2012
	Range of calculated volatility		n/a		49.00%	49.3% - 51.6%
	Dividend yield		n/a		0%	0%
	Range of risk free interest rate		n/a		0.72%	0.62% - 0.92%
	Range of expected term		n/a		5.0 years	4.0 - 5.0 years
Summary of Changes in Restricted Units and Shares	A summary of changes in restricted units and shares during the fiscal year ended December 31, 2014 is as follows:


			Restricted Stock Units									Restricted Stock
			Total Units			Weighted		Weighted		Aggregate		Total			Weighted		Weighted		Aggregate
						Average		Average		Intrinsic		Shares(1,2)			Average		Average		Intrinsic
						Grant Date		Remaining		Value					Grant Date		Remaining		Value
						Fair Value		Contractual							Fair Value		Contractual
								Term									Term
	Non-vested restricted units and shares outstanding as of January 1, 2014			—			—				—		1,137,000		$	17.47		2 years
	Granted			1,451,000			24.62						—			—
	Vested			(63,000	)		24.89						(412,000	)		17.25
	Forfeited			(340,000	)		25.06						(96,000	)		17.08

	Restricted Units and Shares outstanding as of December 31, 2014			1,048,000		$	24.46		2 years	$	20,712		629,000		$	17.68		1 year	$	12,399


	-1	Service-based shares are inclusive of certain restricted stock awards issued pursuant to the MedAssets, Inc. 2010 Special Stock Incentive Plan (the “Plan”). The Plan was adopted by the Company’s Board of Directors on November 23, 2010 in connection with the Broadlane Acquisition pursuant to an exception to the requirement for stockholder approval under NASDAQ rules.
	-2	During the year, approximately 135,000 restricted shares were surrendered from equity award holders to settle their associated tax liability. The tax liability was paid by the Company on their behalf and amounted to approximately $3,197.
Summary of Changes in SSARs	A summary of changes in SSARs during the fiscal year ended December 31, 2014 is as follows:


			Total			Weighted		Weighted		Weighted		Aggregate
			SSARs(1)			Average		Average		Average		Intrinsic
						Grant Date		Base Price		Remaining		Value
						Fair Value				Contractual
										Term
	SSARs outstanding as of January 1, 2014			1,750,000		$	6.41	$	16.52		4 years
	Granted			—			—		—
	Exercised			(388,000	)		6.2		16.35
	Forfeited			(105,000	)		6.66		17.12

	SSARs outstanding as of December 31, 2014			1,257,000		$	6.45	$	16.59		4 years	$	4,598

	SSARs exercisable as of December 31, 2014			808,000		$	6.54	$	17.53		4 years	$	2,352


	-1	During the year, equity award holders surrendered SSARs to settle their associated tax liability. The tax liability was paid by the Company on their behalf and amounted to approximately $219.
Summary of Changes in Outstanding Options	A summary of changes in outstanding options during the fiscal year ended December 31, 2014 is as follows:


			Shares			Weighted		Weighted		Aggregate
						Average		Average		Intrinsic
						Exercise		Remaining		Value
						Price		Contractual
								Term
	Options outstanding as of January 1, 2014			926,000		$	11.89		4 years
	Granted			—			—
	Exercised			(306,000	)		12.5
	Forfeited			(133,000	)		4.87

	Options outstanding as of December 31, 2014			487,000		$	13.42		3 years	$	3,242

	Options exercisable as of December 31, 2014			485,000		$	13.4		3 years	$	3,242

Summary of Exercise Price Range, Weighted Average Exercise Price, and Remaining Contractual Lives	The following table summarizes the exercise price range, weighted average exercise price, and remaining contractual lives for the number of stock options outstanding as of December 31, 2014, 2013 and 2012:


			December 31,			December 31,		December 31,
			2014			2013		2012
	Range of exercise prices		$	2.86 - $23.11		$	1.56 - $22.45	$	1.56 - $23.11
	Number of options outstanding			487,000			926,000		2,342,000
	Weighted average exercise price		$	13.42		$	11.89	$	11.31
	Weighted average remaining contractual life			3.0 years			3.7 years		4.4 years

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Components of Provision for Income Tax Expense (Benefit)	The provision for income tax expense (benefit) is as follows for the years ended December 31:


		2014			2013			2012
	Current expense
	Federal	$	24,812		$	12,580		$	574
	State		2,355			2,089			1,158

	Total current expense		27,167			14,669			1,732
	Deferred benefit
	Federal		(6,654	)		1,791			(3,110	)
	State		1,090			222			(102	)

	Total deferred (benefit) expense		(5,564	)		2,013			(3,212	)

	Provision for income taxes	$	21,603		$	16,682		$	(1,480	)
Reconciliation Between Income Tax Expense (Benefit) and Amount Computed	A reconciliation between reported income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 35 percent is as follows at December 31, 2014, 2013 and 2012:


		2014			2013			2012
	Computed tax expense (benefit)	$	425		$	15,443		$	(2,925	)
	State taxes (net of federal benefit)		2,240			1,534			719
	Goodwill Impairment		18,388			—			—
	Meals & entertainment related to operations		683			(362	)		895
	Domestic production deduction		—			—			290
	Other permanent items		245			139			143
	Research & development credits		(1,050	)		(1,262	)		(196	)
	Uncertain tax positions		(214	)		31			(391	)
	Non deductible compensation		615			1,184			—
	Other		271			(25	)		(15	)

	Provision for income taxes	$	21,603		$	16,682		$	(1,480	)

Components of Deferred Tax Assets and Liabilities	Significant components of the Company’s deferred tax assets and liabilities are as follows at December 31:


		2014			2013
	Deferred tax asset, current
	Accrued expenses	$	3,508		$	4,478
	Accounts receivable		991			967
	Deferred revenue		5,977			7,185
	Net operating loss carryforwards		148			174
	Returns and allowances		960			1,006
	AMT credit		—			3,520

	Deferred tax asset, current		11,584			17,330
	Valuation allowance		(226	)		(1,539	)

	Total deferred tax asset, current		11,358			15,791

	Deferred tax liability, current
	Prepaid expenses		(5,576	)		(11,256	)

	Total deferred tax liability, current		(5,576	)		(11,256	)

	Net deferred tax asset, current	$	5,782		$	4,535



		2014			2013
	Deferred tax asset, non-current
	Capital lease	$	954		$	947
	Capital loss limitation		—			1,016
	Debt issuance costs		628			529
	Deferred compensation		10,272			8,652
	Deferred revenue		2,469			2,395
	Net operating loss carryforwards		4,688			4,813
	Other		326			371

	Deferred tax asset, non-current		19,337			18,723
	Valuation allowance		(3,684	)		(3,412	)

	Total deferred tax asset, non-current		15,653			15,311

	Deferred tax liability, non-current
	Capitalized software costs		(43,832	)		(39,786	)
	Prepaid expenses		(4,961	)		—
	Fixed assets		(4,347	)		(4,929	)
	Intangible assets		(79,120	)		(91,679	)

	Total deferred tax liability, non-current		(132,260	)		(136,394	)

	Net deferred liability, non-current	$	(116,607	)	$	(121,083	)

Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:



	Balance at December 31, 2011	$	1,299
	Additions for tax positions of prior years		50
	Settlements and lapse of statue of limitations		(679	)

	Balance at December 31, 2012	$	670

	Additions based on tax positions related to the current year		223
	Reductions for tax positions of prior years		(17	)

	Balance at December 31, 2013	$	876

	Additions for tax positions of prior years		333
	Decreases for tax positions of prior years		(180	)
	Settlements and lapse of statue of limitations		(459	)

	Balance at December 31, 2014	$	570

Earnings_Loss_Per_Share_Tables

Earnings (Loss) Per Share (Tables)	12 Months Ended
Earnings (Loss) Per Share (Tables)	Dec. 31, 2014
Earnings Per Share [Abstract]
Reconciliation of Basic and Diluted Weighted Average Shares Outstanding	The following table is a reconciliation of the denominator for basic and diluted loss per share for the years ended December 31, 2014, 2013 and 2012.


		Year Ended December 31,
		2014			2013		2012
	Numerator for Basic and Diluted (Loss) Income Per Share:
	Net (loss) income		(20,390	)		27,441		(6,878	)
	Denominator for basic (loss) income per share weighted average shares		59,811,000			59,705,000		57,452,000
	Effect of dilutive securities:
	Stock options		—			590,000		—
	Stock-settled stock appreciation rights		—			267,000		—
	Restricted stock and stock warrants		—			616,000		—

	Denominator for diluted (loss) income per share — adjusted weighted average shares and assumed conversions		59,811,000			61,178,000		57,452,000
	Basic (loss) income per share:
	Basic net (loss) income from continuing operations	$	(0.34	)	$	0.46	$	(0.12	)

	Diluted net (loss) income per share:
	Diluted net (loss) income from continuing operations	$	(0.34	)	$	0.45	$	(0.12	)

Summary of Potentially Dilutive Securities	The following table provides a summary of those potentially dilutive securities that have been excluded from the above calculation of diluted EPS:


		Year Ended December 31,
		2014			2013		2012
	Stock options		258,000			—		878,000
	Stock-settled stock appreciation rights		263,000			—		38,000
	Restricted stock and stock warrants		775,000			—		234,000

	Total		1,296,000			—		1,150,000

Segment_Information_Tables

Segment Information (Tables)	12 Months Ended
Segment Information (Tables)	Dec. 31, 2014
Segment Reporting [Abstract]
Financial Information of Business Segments	The following tables represent our results of operations, by segment, for the fiscal years ended December 31, 2014, 2013 and 2012:



			Years Ended December 31,
			2014				2013				2012
	Revenue:
	SCM
	Gross administrative fees(1)		$	494,927			$	472,113			$	427,698
	Revenue share obligation(1)			(203,564	)			(182,638	)			(160,783	)

	Net administrative fees			291,363				289,475				266,915
	Other service fees(2)			154,242				134,987				126,656

	Total SCM net revenue			445,605				424,462				393,571
	RCM
	Revenue cycle technology			188,958				180,362				169,878
	Revenue cycle services			85,666				75,592				76,672

	Total RCM net revenue			274,624				255,954				246,550

	Total net revenue			720,229				680,416				640,121
	Operating expenses:
	SCM			327,903				317,977				295,486
	RCM			291,575				223,030				214,935
	Corporate			54,290				48,666				44,502

	Total operating expenses			673,768				589,673				554,923

	Operating income (loss):
	SCM			117,702				106,485				98,085
	RCM			(16,951	)			32,924				31,615
	Corporate			(54,290	)			(48,666	)			(44,502	)

	Total operating income			46,461				90,743				85,198

	Interest expense			(45,563	)			(46,907	)			(66,045	)
	Loss on debt extinguishment			—				—				(28,196	)
	Other income			315				287				685

	Income (loss) before income taxes			1,213				44,123				(8,358	)
	Income tax expense (benefit)			21,603				16,682				(1,480	)

	Net (loss) income		$	(20,390	)		$	27,441			$	(6,878	)

	Segment Adjusted EBITDA
	SCM		$	195,003			$	189,393			$	176,893
	RCM			67,440				62,551				59,451

	Total Segment Adjusted EBITDA		$	262,443			$	251,944			$	236,344
	Corporate			(28,406	)			(31,103	)			(29,006	)

	Total Adjusted EBITDA(1)		$	234,037			$	220,841			$	207,338


	-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.
	-2	Other service fees primarily consists of consulting, services and technology fees.



			Years Ended December 31,
			2014				2013				2012
	Capital expenditures(1):
	SCM		$	25,345			$	16,181			$	19,141
RCM			32,805				38,345				35,180
Corporate			5,108				4,292				12,105

Total		$	63,258			$	58,818			$	66,426


-1	Capital expenditures consist of purchases of property and equipment and capitalized software development costs (internal and external use).



		December 31,
		2014				2013
Financial Position:
Accounts receivable, net
SCM		$	74,337			$	38,319
RCM			53,129				49,314
Corporate			275				3

Total accounts receivable, net			127,741				87,636
Other assets
SCM			1,067,039				955,252
RCM			439,333				503,359
Corporate			84,683				67,502

Total other assets			1,591,055				1,526,113

Total assets		$	1,718,796			$	1,613,749

SCM accrued revenue share obligation		$	91,864			$	77,398
Deferred revenue
SCM			51,958				22,775
RCM			39,494				40,117

Total deferred revenue			91,452				62,892
Notes payable			556,000				439,500
Bonds payable			325,000				325,000
Other liabilities
SCM			36,938				36,393
RCM			23,952				26,113
Corporate			147,103				156,664

Total other liabilities			207,993				219,170

Total liabilities		$	1,272,309			$	1,123,960
Segment Adjusted EBITDA to Consolidated Net (Loss) Income	The following table reconciles Segment Adjusted EBITDA to consolidated net (loss) income for each of the fiscal years ended December 31, 2014, 2013 and 2012:


			Year Ended December 31,
			2014				2013				2012
	SCM Adjusted EBITDA		$	195,003			$	189,393			$	176,893
	RCM Adjusted EBITDA			67,440				62,551				59,451

	Total Segment Adjusted EBITDA			262,443				251,944				236,344
	Depreciation			(34,843	)			(29,948	)			(19,991	)
	Depreciation (included in cost of revenue)			(3,131	)			(2,157	)			(1,859	)
	Amortization of intangibles			(57,593	)			(62,723	)			(72,652	)
	Amortization of intangibles (included in cost of revenue)			—				—				(557	)
	Interest expense, net of interest income(1)			—				—				4
	Income tax expense			(62,568	)			(52,600	)			(22,988	)
	Impairment of goodwill(2)			(52,539	)			—				—
	Share-based compensation expense(3)			(9,162	)			(7,922	)			(5,097	)
	Purchase accounting adjustments(4)			(979	)			—				—
	Restructuring, acquisition and integration-related expenses(5)			(3,466	)			(10,070	)			(6,348	)

	Total reportable segment net income			38,162				86,524				106,856
	Corporate net (loss) income			(58,552	)			(59,083	)			(113,734	)

	Consolidated net (loss) income		$	(20,390	)		$	27,441			$	(6,878	)

	-1	Interest income is included in other income (expense) and is not netted against interest expense in our consolidated statements of operations.
	-2	The impairment during the fiscal year ended December 31, 2014 consisted of the write-off of goodwill relating to our revenue cycle services operating unit.
	-3	Represents non-cash share-based compensation to both employees and directors. We believe excluding this non-cash expense allows us to compare our operating performance without regard to the impact of share-based compensation, which varies from period to period based on amount and timing of grants.
	-4	Represents the effect on revenue of adjusting the acquired deferred revenue balance associated with the Sg2 Acquisition to fair value at the acquisition date.
	-5	Represents the amount attributable to restructuring, acquisition and integration-related costs which include costs such as severance, retention, salaries relating to redundant positions, certain performance-related salary-based compensation, operating infrastructure costs and facility consolidation costs.

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	12 Months Ended
Derivative Financial Instruments (Tables)	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments Designated as Cash Flow Hedges on Income and AOCI	The effects of derivative instruments designated as cash flow hedges on income and AOCI are summarized below:


		Fiscal Year Ended December 31,
	Derivatives designated as cash flow hedges	2014		2013		2012
	Total unrealized loss recognized in other comprehensive income — interest rate contracts	$	—	$	—	$	(1,166)
	Total realized loss reclassified into earnings — interest rate contracts	$	—	$	—	$	5,227

Valuation_and_Qualifying_Accou1

Valuation and Qualifying Accounts (Tables)	12 Months Ended
Valuation and Qualifying Accounts (Tables)	Dec. 31, 2014
Allowance for Doubtful Accounts [Member]
Valuation and Qualifying Accounts	Valuation and Qualifying Accounts


			Balance at		Charged to Bad		Write offs Net of			Balance at End
			Beginning of		Debt(1)		Recoveries(2)			of Year
			Year
	Allowance for Doubtful Accounts
	Year ended December 31, 2014		$	2,568	$	195	$	(122	)	$	2,641
	Year ended December 31, 2013			3,046		—		(478	)		2,568
	Year ended December 31, 2012			3,891		735		(1,580	)		3,046

	-1	Additions to the allowance account through the normal course of business are charged to expense.
	-2	Write-offs reduce the balance of accounts receivable and the related allowance for doubtful accounts indicating management’s belief that specific balances are not recoverable.
Self Insurance Accrual [Member]
Valuation and Qualifying Accounts
			Balance at		Charged to Net		Write offs(2)			Balance at End
			Beginning of		Revenue(1)					of Year
			Year
	Client Allowance and Return Reserve
	Year ended December 31, 2014		$	2,673	$	1,125	$	(1,243	)	$	2,555
	Year ended December 31, 2013			2,759		1,675		(1,761	)		2,673
	Year ended December 31, 2012			2,129		2,126		(1,496	)		2,759

	-1	Includes client service allowance and sales returns. Additions to the allowance through the normal course of business reduce net revenue.
	-2	Write-offs reduce the balance of the client allowance and return reserve.
Customer Allowance and Return Reserve [Member]
Valuation and Qualifying Accounts
			Balance at		Charged to		Claims Payments(3)			Balance at End of
			Beginning of		expense(2)					Year
			Year
	Self Insurance Accrual(1)
	Year ended December 31, 2014		$	2,821	$	25,943	$	(26,420	)	$	2,344
	Year ended December 31, 2013			2,621		25,161		(24,961	)		2,821
	Year ended December 31, 2012			2,966		25,505		(25,850	)		2,621

	-1	We have a self-insurance policy to cover our employees’ medical and dental insurance.
	-2	Estimates of insurance claims expected to be incurred through the normal course of business are charged to expense.
	-3	Actual insurance claims payments reduce the self-insurance accrual.

Quarterly_Financial_Informatio1

Quarterly Financial Information (Tables)	12 Months Ended
Quarterly Financial Information (Tables)	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information	Unaudited summarized financial data by quarter for the years ended December 31, 2014 and 2013 is as follows:


		First		Second		Third		Fourth
		Quarter		Quarter		Quarter		Quarter
	Fiscal 2014
	Net revenue	$	170,867	$	175,415	$	175,705	$	198,242
	Gross profit		133,436		135,054		133,266		146,621
	Net income (loss)		7,678		6,596		7,740		(42,404	)
	Net income (loss) per basic share	$	0.13	$	0.11	$	0.13	$	(0.71	)

	Net income (loss) per diluted share	$	0.12	$	0.11	$	0.13	$	(0.71	)


		First		Second		Third		Fourth
		Quarter		Quarter		Quarter		Quarter
	Fiscal 2013
	Net revenue	$	172,837	$	170,742	$	166,371	$	170,466
	Gross profit		138,569		133,246		128,125		128,526
	Net income		7,704		5,084		6,902		7,751
	Net income per basic share	$	0.13	$	0.09	$	0.12	$	0.13

	Net income per diluted share	$	0.13	$	0.08	$	0.11	$	0.13

Description_of_Business_and_Si3

Description of Business and Significant Accounting Policies - Additional Information (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Change in Accounting Estimate [Line Items]
Maturity period of liquid instruments	Three months or less
Cash and cash equivalents	$12,100	$2,790	$13,734	$62,947
Swing-line balance	0	0
Outstanding balance on revolving credit facility	526,417	424,000
Outstanding checks recorded as accrued expenses	0	0
Concentration of credit risk arising from cash deposit held in excess of federally insured amounts	11,600
Average customer relationship service period	6 years
Contract subscription period, Minimum	2 years
Contract subscription period, Maximum	6 years
Goodwill impairment charge	52,539
Goodwill or indefinite-lived intangible asset impairments	52,539	3,551	0
Period of preliminary purchase price measurement	Up to one year
Contingent deferred revenue	8,441	6,516
Advertising expense	2,598	3,196	2,750
Plan contribution	6,535	6,062	5,175
Employer matching contribution for each dollar contributed by employee	50 cents for each dollar
Percentage of compensation contributed by employees to determine employers contribution	6.00%
Comprehensive income (loss)	-20,390	27,441	-2,817
Revolving Credit Facility [Member]
Change in Accounting Estimate [Line Items]
Outstanding balance on revolving credit facility	$152,000	$10,000
Maximum [Member] \| Software [Member]
Change in Accounting Estimate [Line Items]
Finite-lived intangible assets, useful life	5 years
Maximum [Member] \| Customer Base [Member]
Change in Accounting Estimate [Line Items]
Finite-lived intangible assets, useful life	14 years
Maximum [Member] \| Developed Technology [Member]
Change in Accounting Estimate [Line Items]
Finite-lived intangible assets, useful life	7 years
Maximum [Member] \| Trade Name [Member]
Change in Accounting Estimate [Line Items]
Finite-lived intangible assets, useful life	3 years
Minimum [Member] \| Customer Base [Member]
Change in Accounting Estimate [Line Items]
Finite-lived intangible assets, useful life	7 years
Minimum [Member] \| Developed Technology [Member]
Change in Accounting Estimate [Line Items]
Finite-lived intangible assets, useful life	3 years
Minimum [Member] \| Trade Name [Member]
Change in Accounting Estimate [Line Items]
Finite-lived intangible assets, useful life	2 years

Description_of_Business_and_Si4

Description of Business and Significant Accounting Policies - Net Administrative Fee Revenues (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Gross administration fees	$494,927	$472,113	$427,698
Less: Revenue share obligation	-203,564	-182,638	-160,783
Administrative fees, net	$291,363	$289,475	$266,915

Description_of_Business_and_Si5

Description of Business and Significant Accounting Policies - Depreciation of Property and Equipment (Detail)	12 Months Ended
	Dec. 31, 2014
Buildings [Member]
Depreciation Amortization Impairment [Line Items]
Property Plant And Equipment Useful Life	30 years
Furniture and Fixtures [Member]
Depreciation Amortization Impairment [Line Items]
Property Plant And Equipment Useful Life	7 years
Leasehold Improvements [Member]
Depreciation Amortization Impairment [Line Items]
Property Plant And Equipment Useful Life	Term of lease
Minimum [Member] \| Computer and Equipment [Member]
Depreciation Amortization Impairment [Line Items]
Property Plant And Equipment Useful Life	5 years
Minimum [Member] \| Purchased Software and Capitalized Software Development Costs (Internal Use) [Member]
Depreciation Amortization Impairment [Line Items]
Property Plant And Equipment Useful Life	3 years
Maximum [Member] \| Computer and Equipment [Member]
Depreciation Amortization Impairment [Line Items]
Property Plant And Equipment Useful Life	7 years
Maximum [Member] \| Purchased Software and Capitalized Software Development Costs (Internal Use) [Member]
Depreciation Amortization Impairment [Line Items]
Property Plant And Equipment Useful Life	5 years

Description_of_Business_and_Si6

Description of Business and Significant Accounting Policies - Summary of Deferred Revenue (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Deferred Revenue Arrangement [Line Items]
Deferred revenue, total	$91,452	$62,892
Deferred revenue, total	91,452	62,892
Less: Deferred revenue, current portion	-76,034	-46,523
Deferred revenue, non-current portion	15,418	16,369
Software and SaaS Implementation Fees [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue, total	55,152	27,393
Deferred revenue, total	55,152	27,393
Service Fees [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue, total	19,241	22,363
Deferred revenue, total	19,241	22,363
Administrative Fees [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue, total	15,715	10,935
Deferred revenue, total	15,715	10,935
Other Fees [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue, total	1,344	2,201
Deferred revenue, total	$1,344	$2,201

Property_and_Equipment_Propert

Property and Equipment - Property and Equipment, Net (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Property Plant And Equipments [Abstract]
Land	$1,200	$1,200
Buildings	8,821	8,821
Furniture and fixtures	14,806	14,130
Computers and equipment	65,006	58,710
Leasehold improvements	21,904	20,700
Purchased software	37,828	30,931
Capitalized software development costs (internal use)	186,076	147,828
Property and equipment, gross	335,641	282,320
Accumulated depreciation and amortization	-165,323	-124,573
Property and equipment, net	$170,318	$157,747

Property_and_Equipment_Additio

Property and Equipment - Additional Information (Detail) (USD $)	12 Months Ended			0 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Mar. 01, 2013
Property, Plant and Equipment [Line Items]
Leasehold improvement depreciated on a straight line basis	15 years
Property and equipment, net	$170,318	$157,747
Impairment charges related to property and equipment	0	3,551	0
Additions of capitalized cost of computer software development	38,092	38,944
Accumulated amortization related to capitalized costs of software developed for external use	85,555	57,823
Gross carrying value, capitalized software development costs for external use	186,076	147,828
Cost of revenue related to amortization of software (external use)	3,131	2,157	2,416
Facility Consolidation [Member]
Property, Plant and Equipment [Line Items]
Tenant allowance related to an operating lease				10,378
Property and equipment, net	9,110	9,802
Other Assets [Member]
Property, Plant and Equipment [Line Items]
Accumulated amortization related to capitalized costs of software developed for external use	13,845	10,714
Additions of capitalized software development costs for external use	3,429	4,399
Gross carrying value, capitalized software development costs for external use	23,263	19,834
Cost of revenue related to amortization of software (external use)	$3,131	$2,157	$1,859

Goodwill_Components_of_Goodwil

Goodwill - Components of Goodwill (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill, net	$1,058,414	$1,027,847

Goodwill_Changes_in_Goodwill_D

Goodwill - Changes in Goodwill (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 22, 2014	Dec. 31, 2013
Goodwill [Line Items]
Beginning Balance	$1,027,847
RCS impairment loss	-52,539
Ending Balance	1,058,414
SG-2 LLC [Member]
Goodwill [Line Items]
Beginning Balance		81,476
Acquisition	81,476
Ending Balance	81,476	81,476
TRG [Member]
Goodwill [Line Items]
Acquisition	1,630
Operating Segments [Member] \| SCM [Member]
Goodwill [Line Items]
Beginning Balance			645,202
Ending Balance	728,308		645,202
Operating Segments [Member] \| RCM [Member]
Goodwill [Line Items]
Beginning Balance	382,645
RCS impairment loss	-52,539
Ending Balance	330,106
Operating Segments [Member] \| SG-2 LLC [Member] \| SCM [Member]
Goodwill [Line Items]
Acquisition	81,476
Operating Segments [Member] \| TRG [Member] \| SCM [Member]
Goodwill [Line Items]
Acquisition	$1,630

Goodwill_Additional_Informatio

Goodwill - Additional Information (Detail) (USD $)	12 Months Ended	0 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Oct. 02, 2013
Goodwill [Line Items]
Preliminary estimate related to goodwill impairment charge	$52,539
Minimum [Member] \| Operating Segments [Member] \| RCM [Member]
Goodwill [Line Items]
Percentage of estimated Fair value of revenue cycle services exceeding carrying value		10.00%

Other_Intangible_Assets_Intang

Other Intangible Assets - Intangible Assets with Definite Lives (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	576,225	523,847
Accumulated Amortization	-299,818	-256,407
Net	276,407	267,440
Weighted Average [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, useful life	3 years	3 years
Customer Base [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	529,145	510,547
Accumulated Amortization	-287,187	-248,094
Net	241,958	262,453
Customer Base [Member] \| Weighted Average [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, useful life	3 years	3 years
Developed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	43,900	13,300
Accumulated Amortization	-12,375	-8,313
Net	31,525	4,987
Developed Technology [Member] \| Weighted Average [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, useful life	3 years	2 years
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,100
Accumulated Amortization	-100
Net	1,000
Trade Name [Member] \| Weighted Average [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, useful life	2 years
Non-compete Agreement [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	2,080
Accumulated Amortization	-156
Net	1,924
Non-compete Agreement [Member] \| Weighted Average [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, useful life	2 years

Other_Intangible_Assets_Additi

Other Intangible Assets - Additional Information (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Goodwill And Other Intangibles [Line Items]
Amortization of intangibles	$57,593	$62,723	$72,652
Cost of revenue related to amortization of developed technology	3,131	2,157	2,416
Developed Technology [Member]
Goodwill And Other Intangibles [Line Items]
Amortization of intangibles	57,593	62,723	73,209
Cost of revenue related to amortization of developed technology	0	0	557
Developed Technology [Member] \| Operating Segments [Member] \| RCM [Member]
Goodwill And Other Intangibles [Line Items]
Reduction in gross carrying amount and related accumulated amortization Amortization expense recognized		-23,200
Trade Name [Member] \| Operating Segments [Member] \| SCM [Member]
Goodwill And Other Intangibles [Line Items]
Reduction in gross carrying amount and related accumulated amortization Amortization expense recognized		-4,300
Customer Base [Member] \| Operating Segments [Member] \| RCM [Member]
Goodwill And Other Intangibles [Line Items]
Reduction in gross carrying amount and related accumulated amortization Amortization expense recognized	$14,200

Other_Intangible_Assets_Future

Other Intangible Assets - Future Amortization Expense of Definite-Lived Intangible Assets (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
2015	$58,831
2016	51,897
2017	47,715
2018	41,894
2019	37,310
Thereafter	38,760
Net	$276,407	$267,440

Restructuring_Acquisition_and_2

Restructuring, Acquisition and Integration-Related Expenses - Additional Information (Detail) (USD $)	12 Months Ended			0 Months Ended	1 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Sep. 22, 2014	Dec. 31, 2014
Restructuring Acquisition And Integration Charges [Line Items]
Charges incurred	$4,207	$10,070	$6,348
Cash payments	2,909
Restructuring reserve current	1,918				1,918
Restructuring costs under plan	4,207				4,207
Aggregate purchase price of acquisition	141,256
Goodwill	1,058,414	1,027,847			1,058,414
Reduction in net revenue related to fair value of deferred revenue acquired		2,019
Employee Bonuses [Member]
Restructuring Acquisition And Integration Charges [Line Items]
Adjustments to exclude non-recurring expenses related in connection with the acquisition	3,661
Legal, Financial, and Accounting Professional Advisors [Member]
Restructuring Acquisition And Integration Charges [Line Items]
Adjustments to exclude non-recurring expenses related in connection with the acquisition	3,305
Acquisitions [Member] \| SCM [Member]
Restructuring Acquisition And Integration Charges [Line Items]
Assets acquired from other acquisition related activities	3,055				3,055
Current assets acquired from other acquisition related activities	565				565
Goodwill acquired from other acquisition related activities	1,630
Acquisitions [Member] \| SCM [Member] \| Customer Base [Member]
Restructuring Acquisition And Integration Charges [Line Items]
Intangible assets acquired from other acquisition related activities	480
Weighted-average useful life	3 years
Acquisitions [Member] \| SCM [Member] \| Non-compete Agreement [Member]
Restructuring Acquisition And Integration Charges [Line Items]
Intangible assets acquired from other acquisition related activities	380
Weighted-average useful life	3 years
SG-2 LLC [Member]
Restructuring Acquisition And Integration Charges [Line Items]
Percentage of equity interest acquired				100.00%
Aggregate purchase price of acquisition				138,201
Decrease in purchase price					32
Goodwill	81,476			81,476	81,476
Trade accounts receivable	9,198				9,198
Gross amount due under customer contracts	9,598				9,598
Uncollectible amount due under customer contracts	400				400
Fair value of acquired identified intangible assets	65,700				65,700
Adjustment to reduce the carrying value of deferred revenue				1,923
Carrying value of deferred revenue				17,901
Unfavorable lease obligation	995				995
Short-term portion of unfavorable lease obligation	220				220
Cost incurred in connection with acquisition	3,305				3,305
Revenues	11,730
Net income (loss)	-2,408
Current assets acquired from other acquisition related activities	11,090				11,090
Goodwill acquired from other acquisition related activities	$81,476
SG-2 LLC [Member] \| Minimum [Member]
Restructuring Acquisition And Integration Charges [Line Items]
Number of hospitals facilitate	1,500

Restructuring_Acquisition_and_3

Restructuring, Acquisition and Integration-Related Expenses - Summary of Assets Acquired and Liabilities Assumed (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Sep. 22, 2014
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Sep. 22, 2014
Recognized amounts of identifiable assets acquired and liabilities assumed
Goodwill	$1,058,414	$1,027,847
SG-2 LLC [Member]
Loans At Acquisition Date [Line Items]
Fair value of total consideration transferred	138,201
Recognized amounts of identifiable assets acquired and liabilities assumed
Current assets	11,090
Property and equipment	2,559
Intangible assets	65,700
Current liabilities	-21,849
Long-term liabilities	-775
Total identifiable net assets	56,725
Goodwill	81,476		81,476
Total purchase price	$138,201

Restructuring_Acquisition_and_4

Restructuring, Acquisition and Integration-Related Expenses - Summary of Preliminary Fair Value Estimates (Detail) (SG-2 LLC [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Preliminary Estimated fair value	$65,700
Customer Base [Member]
Finite-Lived Intangible Assets [Line Items]
Preliminary Estimated fair value	32,300
Weighted-average useful lives	11 years
Developed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Preliminary Estimated fair value	30,600
Weighted-average useful lives	6 years
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Preliminary Estimated fair value	1,100
Weighted-average useful lives	3 years
Non Compete Agreement [Member]
Finite-Lived Intangible Assets [Line Items]
Preliminary Estimated fair value	$1,700
Weighted-average useful lives	3 years

Restructuring_Acquisition_and_5

Restructuring, Acquisition and Integration-Related Expenses - Proforma of Financial Information (Detail) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Business Combination Increase Decrease To Reflect Liabilities Acquired At Fair Value [Abstract]
Net revenue	$752,117	$715,709
Net (loss) income	($24,225)	$15,473
Basic net (loss) income per share	($0.41)	$0.26
Diluted net (loss) income per share	($0.41)	$0.25
Basic weighted average shares	59,811	59,705
Diluted weighted average shares	59,811	61,178

Notes_and_Bonds_Payable_Summar

Notes and Bonds Payable - Summary of Notes Payable (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Total notes payable	$556,000	$439,500
Bonds payable	325,000	325,000
Total notes and bonds payable	881,000	764,500
Total notes and bonds payable	881,000	764,500
Less: current portions	-29,583	-15,500
Total long-term notes and bonds payable	851,417	749,000
Term A Facility [Member]
Debt Instrument [Line Items]
Total notes payable	225,000	237,500
Total notes and bonds payable	225,000
Total notes and bonds payable	225,000
Term B Facility [Member]
Debt Instrument [Line Items]
Total notes payable	179,000	192,000
Total notes and bonds payable	179,000
Total notes and bonds payable	179,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Total notes payable	152,000	10,000
Total notes and bonds payable	152,000
Total notes and bonds payable	$152,000

Notes_and_Bonds_Payable_Additi

Notes and Bonds Payable - Additional Information (Detail) (USD $)	0 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 08, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
Notes payable		$556,000	$439,500
Outstanding balance on revolving credit facility		526,417	424,000
Amount drawn on swing line loan		0
Outstanding letter of credit under credit facility		147,000
Letters of credit outstanding amount		1,000
Scheduled principal payments		15,500
Increase in revolving committed amount under Credit Agreement	100,000
Revolving committed amount under Credit Agreement	300,000
Debt issuance costs	615	14,075
Principal amount of senior notes		325,000
Percentage owned by subsidiary guarantor		100.00%
Percentage of interest rate on bonds payable		8.00%
Maturity date of debt instrument		15-Nov-18
Amortization of debt issuance costs		3,805	3,807	7,390
Total interest paid, net of amounts capitalized		41,464	45,185
Lease payments included as interest expense		676	676	676
Amount of financial obligation decretion		267	243
Rental income and additional interest expense under lease agreement		438
Future undiscounted payments under lease agreement		1,746
Term A Facility [Member]
Debt Instrument [Line Items]
Notes payable		225,000	237,500
Weighted average interest rate of senior term loan facility		2.49%
Term B Facility [Member]
Debt Instrument [Line Items]
Notes payable		179,000	192,000
Voluntary prepayment on Term B Facility		10,000
Weighted average interest rate of senior term loan facility		4.00%
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Notes payable		152,000	10,000
Outstanding balance on revolving credit facility		152,000	10,000
Voluntary payments on revolving credit facility		40,000
Weighted average interest rate of senior term loan facility		2.48%
Credit Agreement [Member]
Debt Instrument [Line Items]
Notes payable current		$7,833
Maximum [Member]
Debt Instrument [Line Items]
Percentage of consolidated tangible assets and revenues of subsidiaries not providing guarantees		2.50%
Percentage of consolidated earnings before interest taxes depreciation and amortization on consolidated basis of immaterial subsidiaries not providing guarantees		5.00%
Percentage of pledged equity securities of foreign subsidiary		65.00%
Senior Notes Due 2018 [Member]
Debt Instrument [Line Items]
Repurchase percentage of aggregate principal amount plus accrued and unpaid interest		101.00%
Percentage of par value on senior notes		103.00%

Notes_and_Bonds_Payable_Percen

Notes and Bonds Payable - Percentage of Redemption Prices (Detail) (Senior Notes Due 2018 [Member])	12 Months Ended
	Dec. 31, 2014
2014 [Member]
Debt Instrument [Line Items]
Percentage of redemption prices	104.00%
2015 [Member]
Debt Instrument [Line Items]
Percentage of redemption prices	102.00%
2016 and Thereafter [Member]
Debt Instrument [Line Items]
Percentage of redemption prices	100.00%

Notes_and_Bonds_Payable_Debt_M

Notes and Bonds Payable - Debt Maturities and Scheduled Principal Repayments (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Principal Payment in 2015	$29,583
Principal Payment in 2016	28,000
Principal Payment in 2017	331,888
Principal Payment in 2018	328,000
Principal Payment in 2019	163,529
Total notes and bonds payable	881,000	764,500
Term A Facility [Member]
Debt Instrument [Line Items]
Principal Payment in 2015	23,112
Principal Payment in 2016	25,000
Principal Payment in 2017	176,888
Total notes and bonds payable	225,000
Term B Facility [Member]
Debt Instrument [Line Items]
Principal Payment in 2015	6,471
Principal Payment in 2016	3,000
Principal Payment in 2017	3,000
Principal Payment in 2018	3,000
Principal Payment in 2019	163,529
Total notes and bonds payable	179,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Principal Payment in 2017	152,000
Total notes and bonds payable	152,000
Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Principal Payment in 2018	325,000
Total notes and bonds payable	$325,000

Notes_and_Bonds_Payable_Debt_M1

Notes and Bonds Payable - Debt Maturities and Scheduled Principal Repayments (Parenthetical) (Detail) (Mandatory Payment For 2014 [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Mandatory Payment For 2014 [Member]
Debt Instrument [Line Items]
Mandatory excess cash flow payment	$7,833

Notes_and_Bonds_Payable_Future

Notes and Bonds Payable - Future Payments of Finance Obligation (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Debt Disclosure [Abstract]
2015	$1,114
2016	1,114
2017	8,600
Total	10,828
Less: Amounts representing interest	-2,059
Net present value of capital lease obligation	8,769
Net present value of capital lease obligation	8,769
Less: Amount representing current portion	-294	-255
Finance obligation, less current portion	$8,475	$8,781

Commitments_and_Contingencies_1

Commitments and Contingencies - Future Minimum Rental Payments Under Operating Leases (Detail) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
2015	$13,342
2016	8,651
2017	8,956
2018	9,962
2019	8,855
Thereafter	69,796
Total	$119,562

Commitments_and_Contingencies_2

Commitments and Contingencies - Additional Information (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$11,685	$16,635	$11,060
Lease termination fees included in rent expenses		$5,341

Stockholders_Equity_Additional

Stockholders' Equity - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Feb. 26, 2014	Dec. 31, 2013	Aug. 23, 2011
Equity [Abstract]
Preferred stock, shares authorized	50,000,000
Preferred stock, Par value	$0.01
Preferred stock, issued	0		0
Preferred stock, outstanding	0		0
Common stock shares issued in connection with exercise of warrants	13,000
Warrants outstanding	0
Authorized amount for share repurchase program, maximum		$75,000,000		$25,000,000

Stockholders_Equity_Summary_of

Stockholders' Equity - Summary of Amount and Cost of Common Stock Repurchased (Detail) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2012
Equity [Abstract]
Number of shares repurchased	1,784,645	62,334
Cost of shares repurchased	$42,771	$600

ShareBased_Compensation_Additi

Share-Based Compensation - Additional Information (Detail) (USD $)	12 Months Ended				1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2010	Nov. 30, 2014	Sep. 30, 2014	Aug. 31, 2014	31-May-14	Feb. 28, 2014
	Plans	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2010	Nov. 30, 2014	Sep. 30, 2014	Aug. 31, 2014	31-May-14	Feb. 28, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of share based compensation plans	3
Total share-based compensation expense	$17,849,000	$14,496,000	$10,291,000
Income tax benefit recognized from equity awards	6,665,000	5,365,000	3,853,000
Capitalized share-based compensation expenses	0	0	0
Shares reserved under 2008 equity incentive plan available for grant	5,263,000
Share-based payment award, award vesting period	5 years
Share-based Payment Award, Contractual Terms	Seven-year contractual terms
Intrinsic value of options granted	$0	$0	$0
Service based stock options issued	0	0	0
Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	0	0	0
Percentage of price per share of the common stock sold to participating employees				95.00%
Period required for holding stock purchases as per the plan	18 months
Shares reserved under 2008 equity incentive plan available for grant	500,000
Shares of common stock purchased	22,000	24,700
Shares of common stock purchased, amount	494	482
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award, award vesting period	1 year
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award, award vesting period	5 years
Shares issuable to equity holders depending on cumulative revenue growth rate						200,000
Common Stock Option Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of option awards vested over continuous service	10 years
Total unrecognized compensation expense	2,000
Service based stock options issued	0
Fair value of stock options vested	201,000	737,000	2,246,000
Total intrinsic value of stock options exercised	3,370,000	14,180,000	10,606,000
Common Stock Option Awards [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award, award vesting period	3 years
Common Stock Option Awards [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award, award vesting period	5 years
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved under 2008 equity incentive plan available for grant					15,910	100,786	6,328	8,982	1,218,826
Share-based payment award, award vesting period					3 years		3 years
Weighted Average Grant Date Fair Value, Granted	$24.62				$20.72	$21.26	$21.97	$23.54	$25.06
Restricted Stock Units (RSUs) [Member] \| Restricted Common Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant Date Fair Value, Granted	$24.62	$18.44	$14
Restricted stock award, gross	1,451,000
Fair value of shares vested	11,118,000	5,732,000	10,584,000
Total unrecognized compensation expense	17,905,000
Total unrecognized compensation expense will be recognized over a weighted-average period	1 year 6 months
Service-Based Restricted Shares Vesting Each Month Through December 31, 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved under 2008 equity incentive plan available for grant								6,179	63,355
Service-Based Restricted Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved under 2008 equity incentive plan available for grant						30,095		2,107	469,011
Share-based payment award, award vesting period						3 years		3 years	3 years
Performance-Based Restricted Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved under 2008 equity incentive plan available for grant						70,691		348	343,230
Share-based payment award, award vesting period						3 years		3 years	3 years
Percentage to earn from performance-based equity awards	50.00%
Performance-Based Restricted Shares [Member] \| Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award, award vesting period								3 years
Weighted Average Grant Date Fair Value, Granted								$23.54
Shares reserved under 2008 equity incentive plan available for grant								100,000
Shares issuable to equity holders depending on cumulative revenue growth rate								200,000
Performance-Based Restricted Shares [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage to earn from performance-based equity awards	100.00%
Performance-Based Restricted Shares Using EBITDA Performance Metric [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved under 2008 equity incentive plan available for grant								348	343,230
Share-based payment award, award vesting period								3 years	3 years
Percentage to earn from performance-based equity awards	50.00%
Performance-Based Restricted Shares Using EBITDA Performance Metric [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage to earn from performance-based equity awards	100.00%
Stock- settled Appreciation Rights (SSARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant Date Fair Value, Granted	$0	$7.15	$6.07
Fair value of shares vested	1,842,000	3,529,000	4,291,000
Total unrecognized compensation expense	877,000
Total unrecognized compensation expense will be recognized over a weighted-average period	1 year 3 months 18 days
SSARs issued		3,000	653,000
Common stock shares issued	106,000	267,000	19,000
Number of shares, Exercised	388,000	1,340,000	173,000
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock issued in connection with exercise of Stock Options	306,000	1,364,000	1,336,000
Aggregate exercise price of stock issued in connection with exercise of stock options	$3,829,000	$14,808,000	$10,618,000
Restricted Stock [Member] \| Restricted Common Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant Date Fair Value, Granted	$24.62	$18.44	$14
Restricted stock award, gross		1,211,000	438,000

ShareBased_Compensation_Summar

Share-Based Compensation - Summary of Total Share-Based Compensation Expense (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation expense	$17,849,000	$14,496,000	$10,291,000
Cost of Revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation expense	5,510,000	3,866,000	2,165,000
Product Development [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation expense	954,000	635,000	181,000
Selling and Marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation expense	2,622,000	2,251,000	1,489,000
General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation expense	$8,763,000	$7,744,000	$6,456,000

ShareBased_Compensation_Fair_V

Share-Based Compensation - Fair Value of Equity Awards as of Date of Grant Using Black-Scholes Option-Pricing Model Assumptions (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Black Scholes Method Used [Line Items]
Range of calculated volatility, Minimum	49.00%	49.30%
Range of calculated volatility, Maximum		51.60%
Dividend yield	0.00%	0.00%
Range of risk free interest rate, Minimum	0.72%	0.62%
Range of risk free interest rate, Maximum		0.92%
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Black Scholes Method Used [Line Items]
Range of expected term	5 years	4 years
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Black Scholes Method Used [Line Items]
Range of expected term		5 years

ShareBased_Compensation_Summar1

Share-Based Compensation - Summary of Changes in Restricted Units and Shares (Detail) (USD $)	12 Months Ended		1 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Nov. 30, 2014	Sep. 30, 2014	Aug. 31, 2014	31-May-14	Feb. 28, 2014
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding, Beginning balance	1,137,000
Number of shares, Vested	-412,000
Number of shares, Forfeited	-96,000
Number of shares outstanding, Ending balance	629,000	1,137,000
Weighted Average Grant Date Fair Value, Beginning balance	$17.47
Weighted Average Grant Date Fair Value, Vested	$17.25
Weighted Average Grant Date Fair Value, Forfeited	$17.08
Weighted Average Grant Date Fair Value, Ending balance	$17.68	$17.47
Weighted average remaining contractual term, SSARs outstanding	1 year	2 years
Aggregate Intrinsic Value, shares outstanding, Ending balance	$12,399
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, Granted	1,451,000
Number of shares, Vested	-63,000
Number of shares, Forfeited	-340,000
Number of shares outstanding, Ending balance	1,048,000
Weighted Average Grant Date Fair Value, Granted	$24.62		$20.72	$21.26	$21.97	$23.54	$25.06
Weighted Average Grant Date Fair Value, Vested	$24.89
Weighted Average Grant Date Fair Value, Forfeited	$25.06
Weighted Average Grant Date Fair Value, Ending balance	$24.46
Weighted average remaining contractual term, SSARs outstanding	2 years
Aggregate Intrinsic Value, shares outstanding, Ending balance	$20,712

ShareBased_Compensation_Summar2

Share-Based Compensation - Summary of Changes in Restricted Units and Shares (Parenthetical) (Detail) (Restricted Stock [Member], USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares received	135,000
Tax liability paid	$3,197

ShareBased_Compensation_Summar3

Share-Based Compensation - Summary of Changes in SSARs (Detail) (Stock- settled Appreciation Rights (SSARs) [Member], USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Stock- settled Appreciation Rights (SSARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding, Beginning balance	1,750,000
Number of shares, Granted	0
Number of shares, Exercised	-388,000	-1,340,000	-173,000
Number of shares, Forfeited	-105,000
Number of shares outstanding, Ending balance	1,257,000	1,750,000
SSARs exercisable, Ending Balance	808,000
Weighted Average Grant Date Fair Value, Beginning balance	$6.41
Weighted Average Grant Date Fair Value, Granted	$0	$7.15	$6.07
Weighted Average Grant Date Fair Value, Exercised	$6.20
Weighted Average Grant Date Fair Value, Forfeited	$6.66
Weighted Average Grant Date Fair Value, Ending balance	$6.45	$6.41
Weighted average grant date fair value, SSARs exercisable, Ending balance	$6.54
Weighted average base price, Beginning balance	$16.52
Weighted average base price, Granted	$0
Weighted average base period, Exercised	$16.35
Weighted average base price, Forfeited	$17.12
Weighted average base price, Ending balance	$16.59
Weighted average base price, SSARs exercisable, Ending balance	$17.53
Weighted average remaining contractual term, SSARs outstanding	4 years	4 years
Weighted average remaining contractual term, SSARs exercisable, Ending balance	4 years
Aggregate intrinsic value, shares outstanding, Ending balance	$4,598
Aggregate intrinsic value, SSARs exercisable, Ending balance	$2,352

ShareBased_Compensation_Summar4

Share-Based Compensation - Summary of Changes in SSARs (Parenthetical) (Detail) (Stock- settled Appreciation Rights (SSARs) [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Stock- settled Appreciation Rights (SSARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Tax liability paid	$219

ShareBased_Compensation_Summar5

Share-Based Compensation - Summary of Changes in Outstanding Options (Detail) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding, Granted	0	0	0
Common Stock Option Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding, Beginning balance	926,000
Shares outstanding, Granted	0
Stock issued in connection with exercise of Stock Options	-306,000
Shares outstanding, Forfeited	-133,000
Shares outstanding, Ending balance	487,000	926,000
Options exercisable, Ending balance	485,000
Weighted average exercise price, Beginning balance	11.89
Weighted average exercise price, Granted	0
Weighted average exercise price, Exercised	12.5
Weighted average exercise price, Forfeited	4.87
Weighted average exercise price, Ending balance	13.42	11.89
Weighted average exercise price, Options exercisable, Ending balance	13.4
Weighted average remaining contractual term, Options outstanding	3 years	4 years
Weighted average remaining contractual term, Options exercisable	3 years
Aggregate intrinsic value, Options outstanding, Ending balance	3,242
Aggregate intrinsic value, Options exercisable, Ending balance	3,242

ShareBased_Compensation_Summar6

Share-Based Compensation - Summary of Exercise Price Range Weighted Average Exercise Price and Remaining Contractual Lives (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Range of exercise prices, Lower range	$2.86	$1.56	$1.56
Range of exercise prices, Upper range	$23.11	$22.45	$23.11
Number of options outstanding	487,000	926,000	2,342,000
Weighted average exercise price	$13.42	$11.89	$11.31
Weighted average remaining contractual life	3 years	3 years 8 months 12 days	4 years 4 months 24 days

Income_Taxes_Components_of_Pro

Income Taxes - Components of Provision for Income Tax Expense (Benefit) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current expense
Federal	$24,812	$12,580	$574
State	2,355	2,089	1,158
Total current expense	27,167	14,669	1,732
Deferred benefit
Federal	-6,654	1,791	-3,110
State	1,090	222	-102
Total deferred (benefit) expense	-5,564	2,013	-3,212
Provision for income taxes	$21,603	$16,682	($1,480)

Income_Taxes_Reconciliation_Be

Income Taxes - Reconciliation Between Income Tax Expense (Benefit) and Amount Computed (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Computed tax expense (benefit)	$425	$15,443	($2,925)
State taxes (net of federal benefit)	2,240	1,534	719
Goodwill Impairment	18,388
Meals & entertainment related to operations	683	-362	895
Domestic production deduction			290
Other permanent items	245	139	143
Research & development credits	-1,050	-1,262	-196
Uncertain tax positions	-214	31	-391
Non deductible compensation	615	1,184
Other	271	-25	-15
Provision for income taxes	$21,603	$16,682	($1,480)

Income_Taxes_Components_of_Def

Income Taxes - Components of Deferred Tax Assets and Liabilities (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Deferred tax asset, current
Accrued expenses	$3,508	$4,478
Accounts receivable	991	967
Deferred revenue	5,977	7,185
Net operating loss carryforwards	148	174
Returns and allowances	960	1,006
AMT credit		3,520
Deferred tax asset, current	11,584	17,330
Valuation allowance	-226	-1,539
Total deferred tax asset, current	11,358	15,791
Deferred tax liability, current
Prepaid expenses	-5,576	-11,256
Total deferred tax liability, current	-5,576	-11,256
Net deferred tax asset, current	5,782	4,535
Deferred tax asset, non-current
Capital lease	954	947
Capital loss limitation		1,016
Debt issuance costs	628	529
Deferred compensation	10,272	8,652
Deferred revenue	2,469	2,395
Net operating loss carryforwards	4,688	4,813
Other	326	371
Deferred tax asset, non-current	19,337	18,723
Valuation allowance	-3,684	-3,412
Total deferred tax asset, non-current	15,653	15,311
Deferred tax liability, non-current
Capitalized software costs	-43,832	-39,786
Prepaid expenses	-4,961
Fixed assets	-4,347	-4,929
Intangible assets	-79,120	-91,679
Total deferred tax liability, non-current	-132,260	-136,394
Net deferred liability, non-current	($116,607)	($121,083)

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Taxes [Line Items]
Change in valuation allowance	($25)
Cash paid for income taxes	27,438	7,660
Net interest expense and penalties	153	153
Unrecognized tax benefits, interest and penalties accrued	47	47
Interest and penalties payable	279
Uncertain positions that impact effective rate	579
Anticipating unrecognized tax benefits	570	876	670	1,299
Anticipating In Two Thousand Fifteen [Member]
Income Taxes [Line Items]
Anticipating unrecognized tax benefits	520
Capital Loss Carryforward [Member]
Income Taxes [Line Items]
Change in valuation allowance	-1,016
State [Member]
Income Taxes [Line Items]
Net operating loss carry forwards	107,854
Federal [Member]
Income Taxes [Line Items]
Tax credits	$55

Income_Taxes_Reconciliation_of

Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Beginning Balance	$876	$670	$1,299
Additions based on tax positions related to the current year	333	223
Additions for tax positions of prior years			50
Reductions for tax positions of prior years	-180	-17
Settlements and lapse of statue of limitations	-459		-679
Ending Balance	$570	$876	$670

Earnings_Loss_Per_Share_Reconc

Earnings (Loss) Per Share - Reconciliation of Basic and Diluted Weighted Average Shares Outstanding (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Numerator for Basic and Diluted (Loss) Income Per Share:
Net (loss) income	($42,404)	$7,740	$6,596	$7,678	$7,751	$6,902	$5,084	$7,704	($20,390)	$27,441	($6,878)
Denominator for basic (loss) income per share weighted average shares									59,811,000	59,705,000	57,452,000
Effect of dilutive securities:
Stock options										590,000
Stock-settled stock appreciation rights										267,000
Restricted stock and stock warrants										616,000
Denominator for diluted (loss) income per share - adjusted weighted average shares and assumed conversions									59,811,000	61,178,000	57,452,000
Basic (loss) income per share:
Basic net (loss) income from continuing operations	($0.71)	$0.13	$0.11	$0.13	$0.13	$0.12	$0.09	$0.13	($0.34)	$0.46	($0.12)
Diluted net (loss) income per share:
Diluted net (loss) income from continuing operations	($0.71)	$0.13	$0.11	$0.12	$0.13	$0.11	$0.08	$0.13	($0.34)	$0.45	($0.12)

Earnings_Loss_Per_Share_Summar

Earnings (Loss) Per Share - Summary of Potentially Dilutive Securities (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from calculation of diluted EPS	1,296,000	1,150,000
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from calculation of diluted EPS	258,000	878,000
Stock- settled Appreciation Rights (SSARs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from calculation of diluted EPS	263,000	38,000
Restricted Stock and Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities excluded from calculation of diluted EPS	775,000	234,000

Segment_Information_Additional

Segment Information - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2014
	Segment
Segment Reporting [Abstract]
Number of reportable business segments	2

Segment_Information_Financial_

Segment Information - Financial Information of Business Segments (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenue:
Gross administrative fees									$494,927	$472,113	$427,698
Revenue share obligation									-203,564	-182,638	-160,783
Net administrative fees									291,363	289,475	266,915
Other service fees									428,866	390,941	373,206
Total net revenue	198,242	175,705	175,415	170,867	170,466	166,371	170,742	172,837	720,229	680,416	640,121
Operating expenses:
Total operating expenses									673,768	589,673	554,923
Operating income (loss):
Total operating income									46,461	90,743	85,198
Interest expense									-45,563	-46,907	-66,045
Loss on debt extinguishment											-28,196
Other income									315	287	685
Income (loss) before income taxes									1,213	44,123	-8,358
Income tax expense (benefit)									21,603	16,682	-1,480
Net (loss)income	-42,404	7,740	6,596	7,678	7,751	6,902	5,084	7,704	-20,390	27,441	-6,878
Segment Adjusted EBITDA
Total Adjusted EBITDA									234,037	220,841	207,338
Capital expenditures :
Total Capital expenditures									63,258	58,818	66,426
Accounts receivable, net
Total accounts receivable, net	127,741				87,636				127,741	87,636
Other assets
Total other assets	1,591,055				1,526,113				1,591,055	1,526,113
Total assets	1,718,796				1,613,749				1,718,796	1,613,749
Accrued revenue share obligation and rebates	91,864				77,398				91,864	77,398
Deferred revenue
Total deferred revenue	91,452				62,892				91,452	62,892
Notes payable	556,000				439,500				556,000	439,500
Bonds payable	325,000				325,000				325,000	325,000
Other liabilities
Total other liabilities	207,993				219,170				207,993	219,170
Total liabilities	1,272,309				1,123,960				1,272,309	1,123,960
Operating Segments [Member]
Operating income (loss):
Net (loss)income									38,162	86,524	106,856
Segment Adjusted EBITDA
Total Adjusted EBITDA									262,443	251,944	236,344
Deferred revenue
Total deferred revenue	91,452				62,892				91,452	62,892
Notes payable	556,000				439,500				556,000	439,500
Bonds payable	325,000				325,000				325,000	325,000
Corporate, Non-Segment [Member]
Operating expenses:
Total operating expenses									54,290	48,666	44,502
Operating income (loss):
Total operating income									-54,290	-48,666	-44,502
Net (loss)income									-58,552	-59,083	-113,734
Segment Adjusted EBITDA
Total Adjusted EBITDA									-28,406	-31,103	-29,006
Capital expenditures :
Total Capital expenditures									5,108	4,292	12,105
Accounts receivable, net
Total accounts receivable, net	275				3				275	3
Other assets
Total other assets	84,683				67,502				84,683	67,502
Other liabilities
Total other liabilities	147,103				156,664				147,103	156,664
SCM [Member] \| Operating Segments [Member]
Revenue:
Gross administrative fees									494,927	472,113	427,698
Revenue share obligation									-203,564	-182,638	-160,783
Net administrative fees									291,363	289,475	266,915
Other service fees									154,242	134,987	126,656
Total net revenue									445,605	424,462	393,571
Operating expenses:
Total operating expenses									327,903	317,977	295,486
Operating income (loss):
Total operating income									117,702	106,485	98,085
Segment Adjusted EBITDA
Total Adjusted EBITDA									195,003	189,393	176,893
Capital expenditures :
Total Capital expenditures									25,345	16,181	19,141
Accounts receivable, net
Total accounts receivable, net	74,337				38,319				74,337	38,319
Other assets
Total other assets	1,067,039				955,252				1,067,039	955,252
Accrued revenue share obligation and rebates	91,864				77,398				91,864	77,398
Deferred revenue
Total deferred revenue	51,958				22,775				51,958	22,775
Other liabilities
Total other liabilities	36,938				36,393				36,938	36,393
RCM [Member] \| Operating Segments [Member]
Revenue:
Revenue cycle technology									188,958	180,362	169,878
Revenue cycle services									85,666	75,592	76,672
Total net revenue									274,624	255,954	246,550
Operating expenses:
Total operating expenses									291,575	223,030	214,935
Operating income (loss):
Total operating income									-16,951	32,924	31,615
Segment Adjusted EBITDA
Total Adjusted EBITDA									67,440	62,551	59,451
Capital expenditures :
Total Capital expenditures									32,805	38,345	35,180
Accounts receivable, net
Total accounts receivable, net	53,129				49,314				53,129	49,314
Other assets
Total other assets	439,333				503,359				439,333	503,359
Deferred revenue
Total deferred revenue	39,494				40,117				39,494	40,117
Other liabilities
Total other liabilities	$23,952				$26,113				$23,952	$26,113

Segment_Information_Segment_Ad

Segment Information - Segment Adjusted Ebitda Consolidated Net Income (Detail) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total Segment Adjusted EBITDA									$234,037,000	$220,841,000	$207,338,000
Net (loss) income	-42,404,000	7,740,000	6,596,000	7,678,000	7,751,000	6,902,000	5,084,000	7,704,000	-20,390,000	27,441,000	-6,878,000
Depreciation (included in cost of revenue)									-48,096,000	-40,803,000	-30,190,000
Amortization of intangibles									-57,593,000	-62,723,000	-72,652,000
Amortization of intangibles (included in cost of revenue)									-3,131,000	-2,157,000	-2,416,000
Income tax expense									21,603,000	16,682,000	-1,480,000
Impairment of goodwill									-52,539,000
Total share-based compensation expense									-17,849,000	-14,496,000	-10,291,000
Restructuring, acquisition and integration-related expenses									-7,512,000	-10,070,000	-6,348,000
Operating Segments [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total Segment Adjusted EBITDA									262,443,000	251,944,000	236,344,000
Net (loss) income									38,162,000	86,524,000	106,856,000
Segment Reporting Reconciling Items [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Depreciation									-34,843,000	-29,948,000	-19,991,000
Depreciation (included in cost of revenue)									-3,131,000	-2,157,000	-1,859,000
Amortization of intangibles									-57,593,000	-62,723,000	-72,652,000
Amortization of intangibles (included in cost of revenue)											-557,000
Interest expense, net of interest income											4,000
Income tax expense									-62,568,000	-52,600,000	-22,988,000
Impairment of goodwill									-52,539,000
Total share-based compensation expense									-9,162,000	-7,922,000	-5,097,000
Purchase accounting adjustments									-979,000
Restructuring, acquisition and integration-related expenses									-3,466,000	-10,070,000	-6,348,000
Corporate, Non-Segment [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total Segment Adjusted EBITDA									-28,406,000	-31,103,000	-29,006,000
Net (loss) income									-58,552,000	-59,083,000	-113,734,000
SCM [Member] \| Operating Segments [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total Segment Adjusted EBITDA									195,003,000	189,393,000	176,893,000
RCM [Member] \| Operating Segments [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total Segment Adjusted EBITDA									67,440,000	62,551,000	59,451,000
Impairment of goodwill									($52,539,000)

Derivative_Financial_Instrumen2

Derivative Financial Instruments - Additional Information (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012
Offsetting [Abstract]
Expenses paid to counter parties	$8,209
Expenses paid to counter parties, net of tax	$5,227

Derivative_Financial_Instrumen3

Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges on Income and AOCI (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012
Derivatives, Fair Value [Line Items]
Total unrealized loss recognized in other comprehensive income - interest rate contracts	($1,166)
Total realized loss reclassified into earnings - interest rate contracts	5,227
Interest Rate Contracts [Member] \| Cash Flow Hedging [Member]
Derivatives, Fair Value [Line Items]
Total unrealized loss recognized in other comprehensive income - interest rate contracts	-1,166
Total realized loss reclassified into earnings - interest rate contracts	$5,227

Valuation_and_Qualifying_Accou2

Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for Doubtful Accounts [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Year	$2,568	$3,046	$3,891
Charged to Expense	195		735
Write offs Net of Recoveries	-122	-478	-1,580
Balance at End of Year	2,641	2,568	3,046
Customer Allowance and Return Reserve [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Year	2,673	2,759	2,129
Charged to Expense	1,125	1,675	2,126
Write offs	-1,243	-1,761	-1,496
Balance at End of Year	2,555	2,673	2,759
Self Insurance Accrual [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Year	2,821	2,621	2,966
Charged to Expense	25,943	25,161	25,505
Claims Payments	-26,420	-24,961	-25,850
Balance at End of Year	$2,344	$2,821	$2,621

Quarterly_Financial_Informatio2

Quarterly Financial Information - Quarterly Financial Information (Detail) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Information Disclosure [Abstract]
Net revenue	$198,242	$175,705	$175,415	$170,867	$170,466	$166,371	$170,742	$172,837	$720,229	$680,416	$640,121
Gross profit	146,621	133,266	135,054	133,436	128,526	128,125	133,246	138,569
Net income	($42,404)	$7,740	$6,596	$7,678	$7,751	$6,902	$5,084	$7,704	($20,390)	$27,441	($6,878)
Net income (loss) per basic share	($0.71)	$0.13	$0.11	$0.13	$0.13	$0.12	$0.09	$0.13	($0.34)	$0.46	($0.12)
Net income (loss) per diluted share	($0.71)	$0.13	$0.11	$0.12	$0.13	$0.11	$0.08	$0.13	($0.34)	$0.45	($0.12)

Related_Party_Transaction_Addi

Related Party Transaction - Additional Information (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Related Party Transactions [Abstract]
Charges incurred with respect to transactions with Mr. Bardis	$1,621	$2,250	$1,861

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (USD $)	0 Months Ended	1 Months Ended
Subsequent Events - Additional Information (Detail) (USD $)	Feb. 17, 2015	Feb. 28, 2015	Dec. 31, 2014	Feb. 26, 2014	Aug. 23, 2011	Jan. 31, 2015
Subsequent Event [Line Items]
Expected restructuring costs			$4,207,000
Stock Repurchase Program, Authorized Amount				75,000,000	25,000,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Expected restructuring costs						1,600,000
Expiration date of share repurchase program		28-Feb-16
Stock Repurchase Program, Authorized Amount		100,000,000
Transition agreement period	3 years
Annual consulting fee	$650,000